<?xml version="1.0" encoding="UTF-8"?>
<OAI-PMH xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.openarchives.org/OAI/2.0/ http://www.openarchives.org/OAI/2.0/OAI-PMH.xsd">
  <responseDate>2024-05-03T05:07:16Z</responseDate>
  <request verb="GetRecord" identifier="oai:pubmedcentral.nih.gov:5870969" metadataPrefix="pmc">https:/www.ncbi.nlm.nih.gov/pmc/oai/oai.cgi</request>
  <GetRecord>
    <record>
      <header>
        <identifier>oai:pubmedcentral.nih.gov:5870969</identifier>
        <datestamp>2018-04-06</datestamp>
        <setSpec>plosone</setSpec>
        <setSpec>pmc-open</setSpec>
      </header>
      <metadata>
        <article xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xsi:schemaLocation="https://jats.nlm.nih.gov/ns/archiving/1.3/ https://jats.nlm.nih.gov/archiving/1.3/xsd/JATS-archivearticle1-3.xsd" article-type="research-article">
          <front>
            <journal-meta>
              <journal-id journal-id-type="nlm-ta">PLoS One</journal-id>
              <journal-id journal-id-type="iso-abbrev">PLoS ONE</journal-id>
              <journal-id journal-id-type="publisher-id">plos</journal-id>
              <journal-id journal-id-type="pmc">plosone</journal-id>
              <journal-title-group>
                <journal-title>PLoS ONE</journal-title>
              </journal-title-group>
              <issn pub-type="epub">1932-6203</issn>
              <publisher>
                <publisher-name>Public Library of Science</publisher-name>
                <publisher-loc>San Francisco, CA USA</publisher-loc>
              </publisher>
            </journal-meta>
            <article-meta>
              <article-id pub-id-type="accession">PMC5870969</article-id>
              <article-id pub-id-type="pmcid">PMC5870969</article-id>
              <article-id pub-id-type="pmc-uid">5870969</article-id>
              <article-id pub-id-type="pmid">29584752</article-id>
              <article-id pub-id-type="doi">10.1371/journal.pone.0194415</article-id>
              <article-id pub-id-type="publisher-id">PONE-D-17-36723</article-id>
              <article-categories>
                <subj-group subj-group-type="heading">
                  <subject>Research Article</subject>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Medicine and Health Sciences</subject>
                  <subj-group>
                    <subject>Oncology</subject>
                    <subj-group>
                      <subject>Cancers and Neoplasms</subject>
                      <subj-group>
                        <subject>Colorectal Cancer</subject>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Medicine and Health Sciences</subject>
                  <subj-group>
                    <subject>Health Care</subject>
                    <subj-group>
                      <subject>Health Care Policy</subject>
                      <subj-group>
                        <subject>Treatment Guidelines</subject>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Medicine and Health Sciences</subject>
                  <subj-group>
                    <subject>Diagnostic Medicine</subject>
                    <subj-group>
                      <subject>Cancer Detection and Diagnosis</subject>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Medicine and Health Sciences</subject>
                  <subj-group>
                    <subject>Oncology</subject>
                    <subj-group>
                      <subject>Cancer Detection and Diagnosis</subject>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>People and places</subject>
                  <subj-group>
                    <subject>Geographical locations</subject>
                    <subj-group>
                      <subject>North America</subject>
                      <subj-group>
                        <subject>Caribbean</subject>
                        <subj-group>
                          <subject>Puerto Rico</subject>
                        </subj-group>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Social Sciences</subject>
                  <subj-group>
                    <subject>Economics</subject>
                    <subj-group>
                      <subject>Health Economics</subject>
                      <subj-group>
                        <subject>Health Insurance</subject>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Medicine and Health Sciences</subject>
                  <subj-group>
                    <subject>Health Care</subject>
                    <subj-group>
                      <subject>Health Economics</subject>
                      <subj-group>
                        <subject>Health Insurance</subject>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Medicine and Health Sciences</subject>
                  <subj-group>
                    <subject>Oncology</subject>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Medicine and Health Sciences</subject>
                  <subj-group>
                    <subject>Oncology</subject>
                    <subj-group>
                      <subject>Cancer Treatment</subject>
                    </subj-group>
                  </subj-group>
                </subj-group>
                <subj-group subj-group-type="Discipline-v3">
                  <subject>Social Sciences</subject>
                  <subj-group>
                    <subject>Political Science</subject>
                    <subj-group>
                      <subject>Public Policy</subject>
                      <subj-group>
                        <subject>Medicare</subject>
                      </subj-group>
                    </subj-group>
                  </subj-group>
                </subj-group>
              </article-categories>
              <title-group>
                <article-title>Use of adjuvant chemotherapy in patients with stage III colon cancer in Puerto Rico: A population-based study</article-title>
                <alt-title alt-title-type="running-head">Use of adjuvant chemotherapy for stage III colon cancer in Puerto Rico</alt-title>
              </title-group>
              <contrib-group>
                <contrib contrib-type="author">
                  <contrib-id authenticated="true" contrib-id-type="orcid">http://orcid.org/0000-0002-0134-9947</contrib-id>
                  <name>
                    <surname>Ortiz-Ortiz</surname>
                    <given-names>Karen J.</given-names>
                  </name>
                  <role content-type="http://credit.casrai.org/">Conceptualization</role>
                  <role content-type="http://credit.casrai.org/">Data curation</role>
                  <role content-type="http://credit.casrai.org/">Formal analysis</role>
                  <role content-type="http://credit.casrai.org/">Funding acquisition</role>
                  <role content-type="http://credit.casrai.org/">Investigation</role>
                  <role content-type="http://credit.casrai.org/">Methodology</role>
                  <role content-type="http://credit.casrai.org/">Project administration</role>
                  <role content-type="http://credit.casrai.org/">Supervision</role>
                  <role content-type="http://credit.casrai.org/">Visualization</role>
                  <role content-type="http://credit.casrai.org/">Writing – original draft</role>
                  <xref ref-type="aff" rid="aff001">
                    <sup>1</sup>
                  </xref>
                  <xref ref-type="aff" rid="aff002">
                    <sup>2</sup>
                  </xref>
                  <xref ref-type="corresp" rid="cor001">*</xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Tortolero-Luna</surname>
                    <given-names>Guillermo</given-names>
                  </name>
                  <role content-type="http://credit.casrai.org/">Conceptualization</role>
                  <role content-type="http://credit.casrai.org/">Supervision</role>
                  <role content-type="http://credit.casrai.org/">Validation</role>
                  <role content-type="http://credit.casrai.org/">Visualization</role>
                  <role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
                  <xref ref-type="aff" rid="aff001">
                    <sup>1</sup>
                  </xref>
                  <xref ref-type="aff" rid="aff003">
                    <sup>3</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Ríos-Motta</surname>
                    <given-names>Ruth</given-names>
                  </name>
                  <role content-type="http://credit.casrai.org/">Conceptualization</role>
                  <role content-type="http://credit.casrai.org/">Formal analysis</role>
                  <role content-type="http://credit.casrai.org/">Investigation</role>
                  <role content-type="http://credit.casrai.org/">Methodology</role>
                  <role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
                  <xref ref-type="aff" rid="aff002">
                    <sup>2</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Veintidós-Feliú</surname>
                    <given-names>Alejandro</given-names>
                  </name>
                  <role content-type="http://credit.casrai.org/">Data curation</role>
                  <role content-type="http://credit.casrai.org/">Formal analysis</role>
                  <role content-type="http://credit.casrai.org/">Methodology</role>
                  <role content-type="http://credit.casrai.org/">Software</role>
                  <role content-type="http://credit.casrai.org/">Validation</role>
                  <role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
                  <xref ref-type="aff" rid="aff004">
                    <sup>4</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Hunter-Mellado</surname>
                    <given-names>Robert</given-names>
                  </name>
                  <role content-type="http://credit.casrai.org/">Conceptualization</role>
                  <role content-type="http://credit.casrai.org/">Investigation</role>
                  <role content-type="http://credit.casrai.org/">Methodology</role>
                  <role content-type="http://credit.casrai.org/">Visualization</role>
                  <role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
                  <xref ref-type="aff" rid="aff005">
                    <sup>5</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Torres-Cintrón</surname>
                    <given-names>Carlos R.</given-names>
                  </name>
                  <role content-type="http://credit.casrai.org/">Conceptualization</role>
                  <role content-type="http://credit.casrai.org/">Data curation</role>
                  <role content-type="http://credit.casrai.org/">Formal analysis</role>
                  <role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
                  <xref ref-type="aff" rid="aff003">
                    <sup>3</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Suárez-Ramos</surname>
                    <given-names>Tonatiuh</given-names>
                  </name>
                  <role content-type="http://credit.casrai.org/">Conceptualization</role>
                  <role content-type="http://credit.casrai.org/">Data curation</role>
                  <role content-type="http://credit.casrai.org/">Formal analysis</role>
                  <xref ref-type="aff" rid="aff006">
                    <sup>6</sup>
                  </xref>
                </contrib>
                <contrib contrib-type="author">
                  <name>
                    <surname>Magno</surname>
                    <given-names>Priscilla</given-names>
                  </name>
                  <role content-type="http://credit.casrai.org/">Investigation</role>
                  <role content-type="http://credit.casrai.org/">Methodology</role>
                  <role content-type="http://credit.casrai.org/">Validation</role>
                  <role content-type="http://credit.casrai.org/">Writing – review &amp; editing</role>
                  <xref ref-type="aff" rid="aff005">
                    <sup>5</sup>
                  </xref>
                </contrib>
              </contrib-group>
              <aff id="aff001">
                <label>1</label>
                <addr-line>Cancer Control and Population Sciences Program, University of Puerto Rico, Comprehensive Cancer Center, San Juan, Puerto Rico</addr-line>
              </aff>
              <aff id="aff002">
                <label>2</label>
                <addr-line>Department of Health Services Administration, Graduate School of Public Health, Medical Sciences Campus, University of Puerto Rico, San Juan, Puerto Rico0</addr-line>
              </aff>
              <aff id="aff003">
                <label>3</label>
                <addr-line>Puerto Rico Central Cancer Registry, University of Puerto Rico Comprehensive Cancer Center, San Juan, Puerto Rico</addr-line>
              </aff>
              <aff id="aff004">
                <label>4</label>
                <addr-line>San Juan Bautista School of Medicine, Caguas, Puerto Rico</addr-line>
              </aff>
              <aff id="aff005">
                <label>5</label>
                <addr-line>Division of Cancer Medicine, University of Puerto Rico Comprehensive Cancer Center, San Juan, Puerto Rico</addr-line>
              </aff>
              <aff id="aff006">
                <label>6</label>
                <addr-line>College of Natural Science, University of Puerto Rico, Río Piedras Campus, San Juan, Puerto Rico</addr-line>
              </aff>
              <contrib-group>
                <contrib contrib-type="editor">
                  <name>
                    <surname>Beiki</surname>
                    <given-names>Omid</given-names>
                  </name>
                  <role>Editor</role>
                  <xref ref-type="aff" rid="edit1"/>
                </contrib>
              </contrib-group>
              <aff id="edit1">
                <addr-line>Karolinska Institutet, SWEDEN</addr-line>
              </aff>
              <author-notes>
                <fn fn-type="COI-statement" id="coi001">
                  <p><bold>Competing Interests: </bold>The authors have declared that no competing interests exist.</p>
                </fn>
                <corresp id="cor001">* E-mail: <email>karen.ortiz@upr.edu</email></corresp>
              </author-notes>
              <pub-date pub-type="epub">
                <day>27</day>
                <month>3</month>
                <year>2018</year>
              </pub-date>
              <pub-date pub-type="collection">
                <year>2018</year>
              </pub-date>
              <volume>13</volume>
              <issue>3</issue>
              <elocation-id>e0194415</elocation-id>
              <history>
                <date date-type="received">
                  <day>12</day>
                  <month>10</month>
                  <year>2017</year>
                </date>
                <date date-type="accepted">
                  <day>3</day>
                  <month>3</month>
                  <year>2018</year>
                </date>
              </history>
              <permissions>
                <license xlink:href="https://creativecommons.org/publicdomain/zero/1.0/">
                  <license-p>This is an open access article, free of all copyright, and may be freely reproduced, distributed, transmitted, modified, built upon, or otherwise used by anyone for any lawful purpose. The work is made available under the <ext-link ext-link-type="uri" xlink:href="https://creativecommons.org/publicdomain/zero/1.0/">Creative Commons CC0</ext-link> public domain dedication.</license-p>
                </license>
              </permissions>
              <self-uri content-type="pdf" xlink:href="pone.0194415.pdf"/>
              <abstract>
                <sec id="sec001">
                  <title>Objective</title>
                  <p>This study aims to examine factors associated with the use of adjuvant chemotherapy and the use of oxaliplatin after curative resection in stage III colon cancer patients and assesses the effect of their use in three-year survival.</p>
                </sec>
                <sec id="sec002">
                  <title>Methods</title>
                  <p>This retrospective cohort study was conducted using Puerto Rico Central Cancer Registry-Health Insurance Linkage Database. The study cohort consisted of stage III colon cancer patients with a curative surgery in the period 2008–2012. Multivariate logistic regression was used to estimate adjusted odds ratios. Kaplan-Meier methods and Cox proportional hazards models were used to assess the association between adjuvant chemotherapy and oxaliplatin use and overall survival and risk of death, respectively.</p>
                </sec>
                <sec id="sec003">
                  <title>Results</title>
                  <p>Overall, 75% of the study population received adjuvant chemotherapy during the study period. Factors statistically associated with receiving adjuvant chemotherapy within four months after resection included being married (adjusted odds ratio [AOR] 1.64; 95% CI 1.18–2.28; p = 0.003), and being enrolled in Medicare (AOR 1.68; 95% CI: 1.03–2.75; p = 0.039) or Medicaid and Medicare dual eligible (AOR 1.66; 95% CI: 1.06–2.60; p = 0.028). However, patients aged ≥70 years were less likely to receive adjuvant chemotherapy (AOR 0.22; 95%CI 0.14–0.36; p&lt;0.001).</p>
                </sec>
                <sec id="sec004">
                  <title>Discussion</title>
                  <p>We observed a significant reduction in mortality in adjuvant chemotherapy treated patients. Similarly, patients &lt;70 years treated with oxaliplatin had significantly lower risk of death than those who did not, although for patients ≥70 years no statistical significance was achieved. Future studies should assess effective interventions to reduce barriers to access guideline-based recommended colon cancer treatment.</p>
                </sec>
              </abstract>
              <funding-group>
                <award-group id="award001">
                  <funding-source>
                    <institution>National Institute on Minority Health and Health Disparities of the National Institutes of Health</institution>
                  </funding-source>
                  <award-id>S21MD001830</award-id>
                </award-group>
                <award-group id="award002">
                  <funding-source>
                    <institution-wrap>
                      <institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/100000060</institution-id>
                      <institution>National Institute of Allergy and Infectious Diseases</institution>
                    </institution-wrap>
                  </funding-source>
                  <award-id>U54MD007587</award-id>
                </award-group>
                <award-group id="award003">
                  <funding-source>
                    <institution-wrap>
                      <institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/100000054</institution-id>
                      <institution>National Cancer Institute</institution>
                    </institution-wrap>
                  </funding-source>
                  <award-id>5UGICA189862</award-id>
                </award-group>
                <award-group id="award004">
                  <funding-source>
                    <institution-wrap>
                      <institution-id institution-id-type="funder-id">http://dx.doi.org/10.13039/100000030</institution-id>
                      <institution>Centers for Disease Control and Prevention</institution>
                    </institution-wrap>
                  </funding-source>
                  <award-id>5U58-DP003863</award-id>
                </award-group>
                <funding-statement>This study was supported by the National Institute on Minority Health and Health Disparities of the National Institutes of Health under Award Number S21MD001830, the National Institute of Allergy and Infectious Diseases (NIAID) of the National Institutes of Health (Award Number U54MD007587), and by Award Number 5UGICA189862-03 (PR NCI Oncology Research Program Minority / Underserved – Cancer Care Delivery Research). The collection of cancer-incidence data was supported, in part, by the National Program of Cancer Registries (NPCR) of the Centers of Disease Control and Prevention (CDC) by the Puerto Rico Central Cancer Registry, Grant #5U58-DP 003863-05. The content is solely the responsibility of the authors and does not necessarily represent the official views of the NIH, NCI or PRCCR.</funding-statement>
              </funding-group>
              <counts>
                <fig-count count="2"/>
                <table-count count="5"/>
                <page-count count="15"/>
              </counts>
              <custom-meta-group>
                <custom-meta id="data-availability">
                  <meta-name>Data Availability</meta-name>
                  <meta-value>This study includes data from the Puerto Rico Central Cancer Registry (PRCCR), thus data from this study will not be available because of the confidentiality agreement between PRCCR and the authors. Nevertheless, investigators could obtain the data through PRCCR following the confidentiality procedures. PRCCR data can be requested through the following site: <ext-link ext-link-type="uri" xlink:href="http://www.rcpr.org/Datos-de-Cancer/Acceso-a-Datos">http://www.rcpr.org/Datos-de-Cancer/Acceso-a-Datos</ext-link>.</meta-value>
                </custom-meta>
              </custom-meta-group>
            </article-meta>
            <notes>
              <title>Data Availability</title>
              <p>This study includes data from the Puerto Rico Central Cancer Registry (PRCCR), thus data from this study will not be available because of the confidentiality agreement between PRCCR and the authors. Nevertheless, investigators could obtain the data through PRCCR following the confidentiality procedures. PRCCR data can be requested through the following site: <ext-link ext-link-type="uri" xlink:href="http://www.rcpr.org/Datos-de-Cancer/Acceso-a-Datos">http://www.rcpr.org/Datos-de-Cancer/Acceso-a-Datos</ext-link>.</p>
            </notes>
          </front>
          <body>
            <sec sec-type="intro" id="sec005">
              <title>Introduction</title>
              <p>Adherence to recommended evidence-based guidelines is crucial to improve health outcomes. Surgical resection is the standard treatment for patients with colon and rectal cancer. For patients with stage III colon cancer, the National Comprehensive Cancer Network (NCCN) guidelines recommends surgical resection and adjuvant chemotherapy (ACT) [<xref rid="pone.0194415.ref001" ref-type="bibr">1</xref>]. A robust body of evidence indicates that using ACT decreases the risk of recurrence and improves survival among stage III colon cancer patients [<xref rid="pone.0194415.ref002" ref-type="bibr">2</xref>–<xref rid="pone.0194415.ref010" ref-type="bibr">10</xref>]. It has also been demonstrated that including oxaliplatin in the drug combination has significantly improved the disease-free survival and overall survival, particularly in patients &lt;70 years old [<xref rid="pone.0194415.ref003" ref-type="bibr">3</xref>,<xref rid="pone.0194415.ref011" ref-type="bibr">11</xref>–<xref rid="pone.0194415.ref014" ref-type="bibr">14</xref>]. The NCCN guidelines recommend the use of FOLFOX (fluorouracil with modulating leucovorin (FU) and oxaliplatin) and CAPEOX (capecitabine and oxaliplatin) as the preferred ACT regimen [<xref rid="pone.0194415.ref001" ref-type="bibr">1</xref>]. However, the benefit of oxaliplatin in patients age 70 and older has not been confirmed [<xref rid="pone.0194415.ref001" ref-type="bibr">1</xref>,<xref rid="pone.0194415.ref003" ref-type="bibr">3</xref>,<xref rid="pone.0194415.ref008" ref-type="bibr">8</xref>,<xref rid="pone.0194415.ref009" ref-type="bibr">9</xref>]. Nevertheless, even with the proven benefits of ACT, several studies have shown differences in the use of ACT by age, race/ethnicity, type of insurance coverage and socioeconomic status [<xref rid="pone.0194415.ref002" ref-type="bibr">2</xref>,<xref rid="pone.0194415.ref010" ref-type="bibr">10</xref>,<xref rid="pone.0194415.ref011" ref-type="bibr">11</xref>,<xref rid="pone.0194415.ref015" ref-type="bibr">15</xref>–<xref rid="pone.0194415.ref021" ref-type="bibr">21</xref>].</p>
              <p>Puerto Rico, a territory of the United States (US), has a population of approximately 3.4 million, primarily of Hispanic origin (98%) and over 90% of the population has health insurance coverage. In Puerto Rico, approximately 49% of the population (19% in the U.S.) receives health services through Medicaid/CHIP (Government Health Plan), 34% from private insurance (59% in the U.S.), 11% from Medicare/Military (10% in the U.S.), and 6% are uninsured (12% in the U.S.) [<xref rid="pone.0194415.ref022" ref-type="bibr">22</xref>].</p>
              <p>In spite of the high percentage of the Puerto Rico population with access to health insurance, differences in health outcomes remain. For example, our group reported that colorectal cancer patients covered by the Government Health Plan (Medicaid) are diagnosed in more advanced stages and have poorer survival rate than those with private health insurance [<xref rid="pone.0194415.ref023" ref-type="bibr">23</xref>].</p>
              <p>Knowing and understanding the barriers to access to evidence-based health care is fundamental to address these disparities and to reduce the social and economic burden of colon cancer in Puerto Rico. To our knowledge, this is the first study in Puerto Rico exploring the pattern of using guideline-recommended treatment for stage III colon cancer, its impact on health outcomes, and the factors associated with receiving evidence-based treatment. This study aims to examine the following questions: What is the pattern of using guideline-recommended treatment after curative resection of stage III colon cancer? What are the patient and clinical characteristics associated with receiving ACT with or without oxaliplatin after curative resection of stage III colon cancer patients? Is 3-year survival rate of patients that received ACT with or without oxaliplatin different to those who did not?</p>
            </sec>
            <sec sec-type="materials|methods" id="sec006">
              <title>Materials and methods</title>
              <sec id="sec007">
                <title>Data sources</title>
                <p>This retrospective cohort study used the Puerto Rico Central Cancer Registry- Health Insurance Linkage Database (PRCCR-HILD) to identify colon cancer cases diagnosed during the period 2008–2012. The PRCCR-HILD is a resource developed by the PRCCR to conduct cancer care delivery research examining patterns, quality, and outcomes of cancer care across the cancer care continuum in the island. PRCCR law allows the gathering of insurance companies’ administrative claims. The PRCCR-HILD links the PRCCR database to the claims database received from the major health insurance companies in the island including Medicaid, Medicare, and private insured population. Currently, the PRCCR-HILD includes over 180 million claims for approximately 82% of all the cases diagnosed between 2008 and 2014. For the proposed study period (2008–2012), the PRCCR-HILD contains all the insurance claims generated for over 80% of all cancer patients and 85% of all colon cancer patients reported during this period. PRCCR provided information regarding patient’s sociodemographic characteristics, diagnostic variables, tumor variables, and follow-up information. Whereas, treatment information including date of service, procedure codes (CPT/HCPS), National Drug Codes (NDC), diagnostic codes (ICD9-CM and ICD10-CM format), patient information, service provider information, cost of services, and enrollment files, among others, was obtained from the PRCCR-HILD database. PRCCR cases were matched to the health insurance companies data utilization files using a deterministic matching similar to the algorithm used by SEER-Medicare [<xref rid="pone.0194415.ref024" ref-type="bibr">24</xref>]. In addition, PRCCR receives mortality files from the Puerto Rico Demographic Registry, which covers the entire population. Annually, the PRCCR database is linked with mortality files.</p>
              </sec>
              <sec id="sec008">
                <title>Study population</title>
                <p>The preliminary study cohort consisted of patients with adenocarcinoma of colon (excluding appendix and rectum) diagnosed during the period 2008–2012, who fulfilled the American Joint Cancer Committee criteria for stage III and who have had a colon resection. Given that follow-up information was available until December 2015, we included patients diagnosed until 2012 to give all the patients a minimum follow-up time of 3 years. We included only residents of Puerto Rico with a first cancer diagnosis. The study population was limited to those with complete claims information. Patients who died within 30 days of surgery were excluded. <xref ref-type="table" rid="pone.0194415.t001">Table 1</xref> shows selection criteria including case exclusion.</p>
                <table-wrap id="pone.0194415.t001" orientation="portrait" position="float">
                  <object-id pub-id-type="doi">10.1371/journal.pone.0194415.t001</object-id>
                  <label>Table 1</label>
                  <caption>
                    <title>Cohort selection criteria for patients with stage III colon cancer diagnosed during 2008–2012.</title>
                  </caption>
                  <alternatives>
                    <graphic id="pone.0194415.t001g" xlink:href="pone.0194415.t001"/>
                    <table frame="hsides" rules="groups">
                      <colgroup span="1">
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                      </colgroup>
                      <thead>
                        <tr>
                          <th align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1">Exclusion Criteria</th>
                          <th align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1">Exclusions</th>
                          <th align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1">Remaining</th>
                          <th align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1">%</th>
                        </tr>
                      </thead>
                      <tbody>
                        <tr>
                          <td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">Assessed for eligibility</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">-</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">1,638</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">100.0</td>
                        </tr>
                        <tr>
                          <td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">Non-resident of PR at diagnosis</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">6</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">1,632</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">99.6</td>
                        </tr>
                        <tr>
                          <td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">2<sup>nd</sup> and later primary diagnosis of cancer</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">205</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">1,427</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">87.1</td>
                        </tr>
                        <tr>
                          <td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">Patient data not available in claims database or insurance gaps</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">289</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">1,135</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">69.3</td>
                        </tr>
                        <tr>
                          <td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">Non colon resection</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">16</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">1,122</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">68.5</td>
                        </tr>
                        <tr>
                          <td align="left" style="background-color:#FFFFFF" rowspan="1" colspan="1">Death within 30 days of surgery</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">87</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">1,035</td>
                          <td align="center" style="background-color:#FFFFFF" rowspan="1" colspan="1">63.2</td>
                        </tr>
                      </tbody>
                    </table>
                  </alternatives>
                </table-wrap>
              </sec>
              <sec id="sec009">
                <title>Treatment measurements</title>
                <p>To examine factors associated with the use of ACT and the use of oxaliplatin we obtained information from claims data, including pharmacy claims. We included chemotherapy agents that are recommended for colon cancer stage III (fluororacil, leucovorin, capecitabine, oxaliplatin or levoleucovorin) and that were received within four months after the colon surgery. Chemotherapy and surgery codes are documented in the <xref ref-type="supplementary-material" rid="pone.0194415.s001">S1 Table</xref>. A dichotomous variable was generated to indicate if the patient received ACT. Patients with no claims for recommended chemotherapy agents within four months after the colon surgery were categorized into the group who did not receive ACT. Patients who received ACT were classified into those with oxaliplatin agents and those with no oxaliplatin agents.</p>
              </sec>
              <sec id="sec010">
                <title>Covariates</title>
                <p>Patient characteristics included: age at diagnosis (grouped into three categories: &lt;60, 60–69, and ≥70 years), sex, marital status (unmarried, married, and unknown), area of residence at the time of diagnosis (based on Puerto Rico Health Insurance Administration geographic service regions), and comorbidity. Comorbidity was assessed using the Klabunde modification of the Charlson Comorbidity Index (CCI) [<xref rid="pone.0194415.ref025" ref-type="bibr">25</xref>]. For some patients CCI could not be calculated because the claims before the cancer diagnosis were not available. Tumor variables evaluated were year of diagnosis, primary tumor location (distal, proximal, and overlapping/unknown), and histologic grade (well/moderately differentiated, poorly/undifferentiated, and unknown).</p>
              </sec>
              <sec id="sec011">
                <title>Statistical analyses</title>
                <p>We performed a Chi-square or Fisher's exact test to assess the associations between categorical independent variables and the use of ACT or oxaliplatin. Multivariate logistic regression models were used to estimate the adjusted odds ratio (AOR), and their 95% confidence intervals (CI). Variables with a p-value &lt;0.20 in the bivariate analysis were included in the multivariable logistic regression models to adjust for potential confounding variables. The likelihood ratio test was used to assess the significance of interaction terms.</p>
                <p>We used the Kaplan–Meier method to compare the 3-year survival curves among patients who received ACT with those who did not and patients who received oxaliplatin with those who received ACT but not oxaliplatin. Log rank test and Cox were used to evaluate statistical differences between curves. Multivariate Cox regression analysis was performed to estimate the adjusted effect of receiving ACT or oxaliplatin on 3-year overall survival. Propensity scores were calculated to take into account the likelihood of receiving ACT or oxaliplatin. This variable was categorized into deciles and was included as a covariate in the Cox regression models. The proportionality assumption was evaluated using Schoenfeld residuals. To address the no-compliance with the proportionality assumption in our Cox models we stratified by age-groups (&lt;70 years and &gt; = 70 years). All statistical analyses were performed using the Stata/SE statistical software (version 14.2, College Station, TX).</p>
              </sec>
              <sec id="sec012">
                <title>Ethics statement</title>
                <p>The study was summited and approved by the Institutional Review Board of the University of Puerto Rico, Medical Sciences Campus, San Juan, Puerto Rico. The analysis included secondary data with de-identified patient records. All information from patients was held in strict confidence. Patient ID fields within the PRCCR database are encrypted using a bijective function based on prime numbers. Both encrypt and decrypt functions are stored in a secure server. Only the research team of this study had access to patient information, and only information relevant to this study was examined.</p>
              </sec>
            </sec>
            <sec sec-type="results" id="sec013">
              <title>Results</title>
              <p>A total of 1,035 patients with stage III colon cancer were eligible for the study. <xref ref-type="table" rid="pone.0194415.t002">Table 2</xref> shows the study population characteristics by ACT category (receiving/no-receiving). During the study period, 75% of the study population received ACT. The use of ACT varied significantly by age, marital status, and type of insurance coverage (p&lt;0.05). Among patients who did not receive ACT, 64% were 70 years of age and older, 50% were unmarried, and 36% had dual Medicare and Medicaid insurance. There were no statistically significant differences in the use of ACT by sex, CCI, area of residence, year of diagnosis, primary tumor location, and tumor grade (p&gt;0.05).</p>
              <table-wrap id="pone.0194415.t002" orientation="portrait" position="float">
                <object-id pub-id-type="doi">10.1371/journal.pone.0194415.t002</object-id>
                <label>Table 2</label>
                <caption>
                  <title>Characteristics of stage III colon cancer patients by adjuvant chemotherapy (ACT) status.</title>
                </caption>
                <alternatives>
                  <graphic id="pone.0194415.t002g" xlink:href="pone.0194415.t002"/>
                  <table frame="hsides" rules="groups">
                    <colgroup span="1">
                      <col align="left" valign="middle" span="1"/>
                      <col align="left" valign="middle" span="1"/>
                      <col align="left" valign="middle" span="1"/>
                      <col align="left" valign="middle" span="1"/>
                      <col align="left" valign="middle" span="1"/>
                    </colgroup>
                    <thead>
                      <tr>
                        <th align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1">Characteristics</th>
                        <th align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1">Total study population<break/><italic>N (%)</italic></th>
                        <th align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1">ACT (n = 777)<break/><italic>N (%)</italic></th>
                        <th align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1">No ACT (n = 258)<break/><italic>N (%)</italic></th>
                        <th align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1">P-value<xref ref-type="table-fn" rid="t002fn001">*</xref></th>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">
                          <bold>Study population</bold>
                        </td>
                        <td align="center" rowspan="1" colspan="1">1,035 (100)</td>
                        <td align="center" rowspan="1" colspan="1">777 (75)</td>
                        <td align="center" rowspan="1" colspan="1">258 (25)</td>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">
                          <bold>Age group (years)</bold>
                        </td>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1">&lt;0.0001</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">    &lt;60</td>
                        <td align="center" rowspan="1" colspan="1">282 (27)</td>
                        <td align="center" rowspan="1" colspan="1">242 (31)</td>
                        <td align="center" rowspan="1" colspan="1">40 (16)</td>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">    60–69</td>
                        <td align="center" rowspan="1" colspan="1">333 (32)</td>
                        <td align="center" rowspan="1" colspan="1">281 (36)</td>
                        <td align="center" rowspan="1" colspan="1">52 (20)</td>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">    70+</td>
                        <td align="center" rowspan="1" colspan="1">420 (41)</td>
                        <td align="center" rowspan="1" colspan="1">254 (33)</td>
                        <td align="center" rowspan="1" colspan="1">166 (64)</td>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">
                          <bold>Sex</bold>
                        </td>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1">0.190</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">    Male</td>
                        <td align="center" rowspan="1" colspan="1">538 (52)</td>
                        <td align="center" rowspan="1" colspan="1">413 (53)</td>
                        <td align="center" rowspan="1" colspan="1">125 (48)</td>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">    Female</td>
                        <td align="center" rowspan="1" colspan="1">497 (48)</td>
                        <td align="center" rowspan="1" colspan="1">364 (47)</td>
                        <td align="center" rowspan="1" colspan="1">133 (52)</td>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">
                          <bold>Marital status</bold>
                        </td>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1">&lt;0.0001</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">    Unmarried</td>
                        <td align="center" rowspan="1" colspan="1">401 (39)</td>
                        <td align="center" rowspan="1" colspan="1">273 (35)</td>
                        <td align="center" rowspan="1" colspan="1">128 (50)</td>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">    Married</td>
                        <td align="center" rowspan="1" colspan="1">575 (56)</td>
                        <td align="center" rowspan="1" colspan="1">457 (59)</td>
                        <td align="center" rowspan="1" colspan="1">118 (46)</td>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">    Unknown</td>
                        <td align="center" rowspan="1" colspan="1">59 (6)</td>
                        <td align="center" rowspan="1" colspan="1">47 (6)</td>
                        <td align="center" rowspan="1" colspan="1">12 (5)</td>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">
                          <bold>CCI</bold>
                        </td>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1">0.090</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">    0</td>
                        <td align="center" rowspan="1" colspan="1">575 (56)</td>
                        <td align="center" rowspan="1" colspan="1">445 (57)</td>
                        <td align="center" rowspan="1" colspan="1">130 (50)</td>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">    1</td>
                        <td align="center" rowspan="1" colspan="1">197 (19)</td>
                        <td align="center" rowspan="1" colspan="1">142 (18)</td>
                        <td align="center" rowspan="1" colspan="1">55 (21)</td>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">    ≥2</td>
                        <td align="center" rowspan="1" colspan="1">198 (19)</td>
                        <td align="center" rowspan="1" colspan="1">138 (18)</td>
                        <td align="center" rowspan="1" colspan="1">60 (23)</td>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">    Unknown</td>
                        <td align="center" rowspan="1" colspan="1">65 (6)</td>
                        <td align="center" rowspan="1" colspan="1">52 (7)</td>
                        <td align="center" rowspan="1" colspan="1">13 (5)</td>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">
                          <bold>Type of insurance coverage</bold>
                        </td>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1">0.001</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">    Medicaid</td>
                        <td align="center" rowspan="1" colspan="1">274 (26)</td>
                        <td align="center" rowspan="1" colspan="1">209 (27)</td>
                        <td align="center" rowspan="1" colspan="1">65 (25)</td>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">    Private</td>
                        <td align="center" rowspan="1" colspan="1">230 (22)</td>
                        <td align="center" rowspan="1" colspan="1">194 (25)</td>
                        <td align="center" rowspan="1" colspan="1">36 (14)</td>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">    Medicare/Medicaid</td>
                        <td align="center" rowspan="1" colspan="1">319 (31)</td>
                        <td align="center" rowspan="1" colspan="1">227 (29)</td>
                        <td align="center" rowspan="1" colspan="1">92 (36)</td>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">    Medicare</td>
                        <td align="center" rowspan="1" colspan="1">212 (21)</td>
                        <td align="center" rowspan="1" colspan="1">147 (19)</td>
                        <td align="center" rowspan="1" colspan="1">65 (25)</td>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">
                          <bold>Region</bold>
                        </td>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1">0.092</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">    Metro-North</td>
                        <td align="center" rowspan="1" colspan="1">185 (18)</td>
                        <td align="center" rowspan="1" colspan="1">140 (18)</td>
                        <td align="center" rowspan="1" colspan="1">45 (17)</td>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">    San Juan</td>
                        <td align="center" rowspan="1" colspan="1">98 (9)</td>
                        <td align="center" rowspan="1" colspan="1">71 (9)</td>
                        <td align="center" rowspan="1" colspan="1">27 (10)</td>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">    East</td>
                        <td align="center" rowspan="1" colspan="1">167 (16)</td>
                        <td align="center" rowspan="1" colspan="1">133 (17)</td>
                        <td align="center" rowspan="1" colspan="1">34 (13)</td>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">    North</td>
                        <td align="center" rowspan="1" colspan="1">128 (12)</td>
                        <td align="center" rowspan="1" colspan="1">102 (13)</td>
                        <td align="center" rowspan="1" colspan="1">26 (10)</td>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">    Northeast</td>
                        <td align="center" rowspan="1" colspan="1">122 (12)</td>
                        <td align="center" rowspan="1" colspan="1">79 (10)</td>
                        <td align="center" rowspan="1" colspan="1">43 (17)</td>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">    Southeast</td>
                        <td align="center" rowspan="1" colspan="1">98 (9)</td>
                        <td align="center" rowspan="1" colspan="1">73 (9)</td>
                        <td align="center" rowspan="1" colspan="1">25 (10)</td>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">    Southwest</td>
                        <td align="center" rowspan="1" colspan="1">73 (7)</td>
                        <td align="center" rowspan="1" colspan="1">59 (8)</td>
                        <td align="center" rowspan="1" colspan="1">14 (5)</td>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">    West</td>
                        <td align="center" rowspan="1" colspan="1">164 (16)</td>
                        <td align="center" rowspan="1" colspan="1">120 (15)</td>
                        <td align="center" rowspan="1" colspan="1">44 (17)</td>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">
                          <bold>Diagnosis year</bold>
                        </td>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1">0.321</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">    2008</td>
                        <td align="center" rowspan="1" colspan="1">182 (18)</td>
                        <td align="center" rowspan="1" colspan="1">135 (17)</td>
                        <td align="center" rowspan="1" colspan="1">47 (18)</td>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">    2009</td>
                        <td align="center" rowspan="1" colspan="1">193 (19)</td>
                        <td align="center" rowspan="1" colspan="1">151 (19)</td>
                        <td align="center" rowspan="1" colspan="1">42 (16)</td>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">    2010</td>
                        <td align="center" rowspan="1" colspan="1">223 (22)</td>
                        <td align="center" rowspan="1" colspan="1">171 (22)</td>
                        <td align="center" rowspan="1" colspan="1">52 (20)</td>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">    2011</td>
                        <td align="center" rowspan="1" colspan="1">202 (20)</td>
                        <td align="center" rowspan="1" colspan="1">155 (20)</td>
                        <td align="center" rowspan="1" colspan="1">47 (18)</td>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">    2012</td>
                        <td align="center" rowspan="1" colspan="1">235 (23)</td>
                        <td align="center" rowspan="1" colspan="1">165 (21)</td>
                        <td align="center" rowspan="1" colspan="1">70 (27)</td>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">
                          <bold>Primary tumor location</bold>
                        </td>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1">0.138</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">    Distal</td>
                        <td align="center" rowspan="1" colspan="1">435 (42)</td>
                        <td align="center" rowspan="1" colspan="1">340 (44)</td>
                        <td align="center" rowspan="1" colspan="1">95 (37)</td>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">    Proximal</td>
                        <td align="center" rowspan="1" colspan="1">589 (57)</td>
                        <td align="center" rowspan="1" colspan="1">429 (55)</td>
                        <td align="center" rowspan="1" colspan="1">160 (62)</td>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">    Other</td>
                        <td align="center" rowspan="1" colspan="1">11 (1)</td>
                        <td align="center" rowspan="1" colspan="1">8 (1)</td>
                        <td align="center" rowspan="1" colspan="1">3 (1)</td>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">
                          <bold>Tumor grade</bold>
                        </td>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1">0.164</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">    Well/moderately differentiated</td>
                        <td align="center" rowspan="1" colspan="1">839 (81)</td>
                        <td align="center" rowspan="1" colspan="1">639 (82)</td>
                        <td align="center" rowspan="1" colspan="1">200 (78)</td>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">    Poorly/undifferentiated</td>
                        <td align="center" rowspan="1" colspan="1">116 (11)</td>
                        <td align="center" rowspan="1" colspan="1">79 (10)</td>
                        <td align="center" rowspan="1" colspan="1">37 (14)</td>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">    Unknown</td>
                        <td align="center" rowspan="1" colspan="1">80 (8)</td>
                        <td align="center" rowspan="1" colspan="1">59 (8)</td>
                        <td align="center" rowspan="1" colspan="1">21 (8)</td>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                    </tbody>
                  </table>
                </alternatives>
                <table-wrap-foot>
                  <fn id="t002fn001">
                    <p>* p values were calculated using chi-squared test or Fisher's exact test.</p>
                  </fn>
                </table-wrap-foot>
              </table-wrap>
              <p><xref ref-type="table" rid="pone.0194415.t003">Table 3</xref> compares the characteristics of subjects receiving oxaliplatin to those no-receiving oxaliplatin as part of their ACT. Among patients receiving ACT, 76% received oxaliplatin as a part of their treatment. Receiving oxaliplatin differed statistically by age-groups, type of insurance coverage, and year of diagnosis. Patients &lt;70 years, dual Medicare/Medicaid, and those diagnosed in 2008 were less likely to receive oxaliplatin (p&lt;0.05). No significant differences were observed by sex (p = 0.412), marital status (p = 0.102), CCI (p = 0.208), region (p = 0.254), primary tumor location (p = 0.079), and tumor grade (p = 0.164).</p>
              <table-wrap id="pone.0194415.t003" orientation="portrait" position="float">
                <object-id pub-id-type="doi">10.1371/journal.pone.0194415.t003</object-id>
                <label>Table 3</label>
                <caption>
                  <title>Characteristics of stage III colon cancer patients who used ACT by oxaliplatin Receipt status.</title>
                </caption>
                <alternatives>
                  <graphic id="pone.0194415.t003g" xlink:href="pone.0194415.t003"/>
                  <table frame="hsides" rules="groups">
                    <colgroup span="1">
                      <col align="left" valign="middle" span="1"/>
                      <col align="left" valign="middle" span="1"/>
                      <col align="left" valign="middle" span="1"/>
                      <col align="left" valign="middle" span="1"/>
                      <col align="left" valign="middle" span="1"/>
                    </colgroup>
                    <thead>
                      <tr>
                        <th align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1">Characteristics</th>
                        <th align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1">Patients Receiving ACT<break/>N (%)</th>
                        <th align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1">Oxaliplatin<break/>N (%)</th>
                        <th align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1">No Oxaliplatin<break/>N (%)</th>
                        <th align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1">P-value</th>
                      </tr>
                    </thead>
                    <tbody>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">Study Population</td>
                        <td align="center" rowspan="1" colspan="1">777 (100)</td>
                        <td align="center" rowspan="1" colspan="1">591 (76)</td>
                        <td align="center" rowspan="1" colspan="1">186 (24)</td>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">
                          <bold>Age group (years)</bold>
                        </td>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1">&lt;0.0001</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">    &lt;60</td>
                        <td align="center" rowspan="1" colspan="1">242 (31)</td>
                        <td align="center" rowspan="1" colspan="1">203 (34)</td>
                        <td align="center" rowspan="1" colspan="1">39 (21)</td>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">    60–69</td>
                        <td align="center" rowspan="1" colspan="1">281 (36)</td>
                        <td align="center" rowspan="1" colspan="1">231 (39)</td>
                        <td align="center" rowspan="1" colspan="1">50 (27)</td>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">    70+</td>
                        <td align="center" rowspan="1" colspan="1">254 (33)</td>
                        <td align="center" rowspan="1" colspan="1">157 (27)</td>
                        <td align="center" rowspan="1" colspan="1">97 (52)</td>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">
                          <bold>Sex</bold>
                        </td>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1">0.412</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">    Male</td>
                        <td align="center" rowspan="1" colspan="1">413 (53)</td>
                        <td align="center" rowspan="1" colspan="1">319 (54)</td>
                        <td align="center" rowspan="1" colspan="1">94 (51)</td>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">    Female</td>
                        <td align="center" rowspan="1" colspan="1">364 (47)</td>
                        <td align="center" rowspan="1" colspan="1">272 (46)</td>
                        <td align="center" rowspan="1" colspan="1">92 (50)</td>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">
                          <bold>Marital Status</bold>
                        </td>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1">0.102</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">    Unmarried</td>
                        <td align="center" rowspan="1" colspan="1">273 (35)</td>
                        <td align="center" rowspan="1" colspan="1">206 (35)</td>
                        <td align="center" rowspan="1" colspan="1">67 (36)</td>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">    Married</td>
                        <td align="center" rowspan="1" colspan="1">457 (59)</td>
                        <td align="center" rowspan="1" colspan="1">355 (60)</td>
                        <td align="center" rowspan="1" colspan="1">102 (55)</td>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">    Unknown</td>
                        <td align="center" rowspan="1" colspan="1">47 (6)</td>
                        <td align="center" rowspan="1" colspan="1">30 (5)</td>
                        <td align="center" rowspan="1" colspan="1">17 (9)</td>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">
                          <bold>CCI</bold>
                        </td>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1">0.208</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">    0</td>
                        <td align="center" rowspan="1" colspan="1">445 (57)</td>
                        <td align="center" rowspan="1" colspan="1">338 (57)</td>
                        <td align="center" rowspan="1" colspan="1">107 (58)</td>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">    1</td>
                        <td align="center" rowspan="1" colspan="1">142 (18)</td>
                        <td align="center" rowspan="1" colspan="1">114 (19)</td>
                        <td align="center" rowspan="1" colspan="1">28 (15)</td>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">    ≥2</td>
                        <td align="center" rowspan="1" colspan="1">138 (18)</td>
                        <td align="center" rowspan="1" colspan="1">97 (16)</td>
                        <td align="center" rowspan="1" colspan="1">41 (22)</td>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">    Unknown</td>
                        <td align="center" rowspan="1" colspan="1">52 (7)</td>
                        <td align="center" rowspan="1" colspan="1">42 (5)</td>
                        <td align="center" rowspan="1" colspan="1">10 (5)</td>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">
                          <bold>Type of insurance coverage</bold>
                        </td>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1">&lt;0.0001</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">    Medicaid</td>
                        <td align="center" rowspan="1" colspan="1">194 (25)</td>
                        <td align="center" rowspan="1" colspan="1">167 (28)</td>
                        <td align="center" rowspan="1" colspan="1">27 (15)</td>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">    Private</td>
                        <td align="center" rowspan="1" colspan="1">209 (27)</td>
                        <td align="center" rowspan="1" colspan="1">168 (28)</td>
                        <td align="center" rowspan="1" colspan="1">41 (22)</td>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">    Medicare/Medicaid</td>
                        <td align="center" rowspan="1" colspan="1">227 (19)</td>
                        <td align="center" rowspan="1" colspan="1">161 (27)</td>
                        <td align="center" rowspan="1" colspan="1">66 (36)</td>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">    Medicare</td>
                        <td align="center" rowspan="1" colspan="1">147 (19)</td>
                        <td align="center" rowspan="1" colspan="1">95 (16)</td>
                        <td align="center" rowspan="1" colspan="1">52 (28)</td>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">
                          <bold>Region</bold>
                        </td>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1">0.254</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">    Metro-North</td>
                        <td align="center" rowspan="1" colspan="1">140 (18)</td>
                        <td align="center" rowspan="1" colspan="1">104 (18)</td>
                        <td align="center" rowspan="1" colspan="1">36 (19)</td>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">    San Juan</td>
                        <td align="center" rowspan="1" colspan="1">71 (9)</td>
                        <td align="center" rowspan="1" colspan="1">58 (10)</td>
                        <td align="center" rowspan="1" colspan="1">13 (7)</td>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">    East</td>
                        <td align="center" rowspan="1" colspan="1">133 (17)</td>
                        <td align="center" rowspan="1" colspan="1">95 (16)</td>
                        <td align="center" rowspan="1" colspan="1">38 (20)</td>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">    North</td>
                        <td align="center" rowspan="1" colspan="1">102 (13)</td>
                        <td align="center" rowspan="1" colspan="1">72 (12)</td>
                        <td align="center" rowspan="1" colspan="1">30 (16)</td>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">    Northeast</td>
                        <td align="center" rowspan="1" colspan="1">79 (10)</td>
                        <td align="center" rowspan="1" colspan="1">59 (10)</td>
                        <td align="center" rowspan="1" colspan="1">20 (11)</td>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">    Southeast</td>
                        <td align="center" rowspan="1" colspan="1">73 (9)</td>
                        <td align="center" rowspan="1" colspan="1">62 (10)</td>
                        <td align="center" rowspan="1" colspan="1">11 (6)</td>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">    Southwest</td>
                        <td align="center" rowspan="1" colspan="1">59 (8)</td>
                        <td align="center" rowspan="1" colspan="1">45 (8)</td>
                        <td align="center" rowspan="1" colspan="1">14 (8)</td>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">    West</td>
                        <td align="center" rowspan="1" colspan="1">120 (15)</td>
                        <td align="center" rowspan="1" colspan="1">96 (16)</td>
                        <td align="center" rowspan="1" colspan="1">24 (13)</td>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">
                          <bold>Diagnosis year</bold>
                        </td>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1">0.006</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">    2008</td>
                        <td align="center" rowspan="1" colspan="1">135 (17)</td>
                        <td align="center" rowspan="1" colspan="1">88 (15)</td>
                        <td align="center" rowspan="1" colspan="1">47 (25)</td>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">    2009</td>
                        <td align="center" rowspan="1" colspan="1">151 (19)</td>
                        <td align="center" rowspan="1" colspan="1">115 (20)</td>
                        <td align="center" rowspan="1" colspan="1">36 (19)</td>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">    2010</td>
                        <td align="center" rowspan="1" colspan="1">171 (22)</td>
                        <td align="center" rowspan="1" colspan="1">136 (23)</td>
                        <td align="center" rowspan="1" colspan="1">35 (19)</td>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">    2011</td>
                        <td align="center" rowspan="1" colspan="1">155 (20)</td>
                        <td align="center" rowspan="1" colspan="1">115 (20)</td>
                        <td align="center" rowspan="1" colspan="1">40 (22)</td>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">    2012</td>
                        <td align="center" rowspan="1" colspan="1">165 (21)</td>
                        <td align="center" rowspan="1" colspan="1">137 (23)</td>
                        <td align="center" rowspan="1" colspan="1">28 (15)</td>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">
                          <bold>Primary tumor location</bold>
                        </td>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1">0.079</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">    Distal</td>
                        <td align="center" rowspan="1" colspan="1">340 (44)</td>
                        <td align="center" rowspan="1" colspan="1">267 (45)</td>
                        <td align="center" rowspan="1" colspan="1">73 (39)</td>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">    Proximal</td>
                        <td align="center" rowspan="1" colspan="1">429 (55)</td>
                        <td align="center" rowspan="1" colspan="1">316 (53)</td>
                        <td align="center" rowspan="1" colspan="1">113 (61)</td>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">    Other</td>
                        <td align="center" rowspan="1" colspan="1">8 (1)</td>
                        <td align="center" rowspan="1" colspan="1">8 (1)</td>
                        <td align="center" rowspan="1" colspan="1">0 (0)</td>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">
                          <bold>Tumor grade</bold>
                        </td>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1"/>
                        <td align="center" rowspan="1" colspan="1">0.164</td>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">    Well/moderately differentiated</td>
                        <td align="center" rowspan="1" colspan="1">839 (81)</td>
                        <td align="center" rowspan="1" colspan="1">639 (82)</td>
                        <td align="center" rowspan="1" colspan="1">200 (78)</td>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">    Poorly/undifferentiated</td>
                        <td align="center" rowspan="1" colspan="1">116 (11)</td>
                        <td align="center" rowspan="1" colspan="1">79 (10)</td>
                        <td align="center" rowspan="1" colspan="1">37 (14)</td>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                      <tr>
                        <td align="left" rowspan="1" colspan="1">    Unknown</td>
                        <td align="center" rowspan="1" colspan="1">80 (8)</td>
                        <td align="center" rowspan="1" colspan="1">59 (8)</td>
                        <td align="center" rowspan="1" colspan="1">21 (8)</td>
                        <td align="center" rowspan="1" colspan="1"/>
                      </tr>
                    </tbody>
                  </table>
                </alternatives>
              </table-wrap>
              <sec id="sec014">
                <title>Use of ACT</title>
                <p>Results from the multivariate logistic model for ACT use are shown in <xref ref-type="table" rid="pone.0194415.t004">Table 4</xref>. Compared to patients aged &lt;60 years, patients aged ≥70 years were less likely to receive ACT (AOR 0.22; 95% CI 0.13–0.35; p&lt;0.001). Whereas, compared with patients enrolled in Medicaid, patients enrolled in Medicare (AOR 1.68; 95% CI: 1.03–2.75; p = 0.039) and those with dual enrollment for Medicare and Medicaid (AOR 1.66; 95% CI: 1.06–2.60; p = 0.028) were more likely to receive ACT. Likewise, patients enrolled in private insurance were more likely to receive ACT than patients enrolled in Medicaid; however, this association did not reach statistical significance (AOR 1.57; 95% CI: 0.95–2.58; p  =  0.076). In addition, married patients were more likely to receive ACT (AOR 1.64; 95% CI 1.18–2.28; p = 0.003) and those living in the Northeast region of the island were less likely to received ACT (AOR 0.58; 95% CI 0.34–0.99; p = 0.046).</p>
                <table-wrap id="pone.0194415.t004" orientation="portrait" position="float">
                  <object-id pub-id-type="doi">10.1371/journal.pone.0194415.t004</object-id>
                  <label>Table 4</label>
                  <caption>
                    <title>Predictors of Receipt ACT.</title>
                  </caption>
                  <alternatives>
                    <graphic id="pone.0194415.t004g" xlink:href="pone.0194415.t004"/>
                    <table frame="hsides" rules="groups">
                      <colgroup span="1">
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                        <col align="left" valign="middle" span="1"/>
                      </colgroup>
                      <thead>
                        <tr>
                          <th align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1">Characteristics</th>
                          <th align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1">AOR (95% CI)</th>
                          <th align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1">P-value</th>
                        </tr>
                      </thead>
                      <tbody>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>Age group (years)</bold>
                          </td>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">    &lt;60</td>
                          <td align="center" rowspan="1" colspan="1">1.00</td>
                          <td align="center" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">    60–69</td>
                          <td align="center" rowspan="1" colspan="1">0.84 (0.52–1.36)</td>
                          <td align="center" rowspan="1" colspan="1">0.489</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">    70+</td>
                          <td align="center" rowspan="1" colspan="1">0.22 (0.13–0.35)</td>
                          <td align="center" rowspan="1" colspan="1">&lt;0.0001</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>Sex</bold>
                          </td>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">    Male</td>
                          <td align="center" rowspan="1" colspan="1">1.00</td>
                          <td align="center" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">    Female</td>
                          <td align="center" rowspan="1" colspan="1">1.05 (0.76–1.45)</td>
                          <td align="center" rowspan="1" colspan="1">0.764</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>Marital status</bold>
                          </td>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">    Unmarried</td>
                          <td align="center" rowspan="1" colspan="1">1.00</td>
                          <td align="center" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">    Married</td>
                          <td align="center" rowspan="1" colspan="1">1.64 (1.18–2.28)</td>
                          <td align="center" rowspan="1" colspan="1">0.003</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">    Unknown</td>
                          <td align="center" rowspan="1" colspan="1">1.92 (0.94–3.89)</td>
                          <td align="center" rowspan="1" colspan="1">0.072</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>CCI</bold>
                          </td>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">    0</td>
                          <td align="center" rowspan="1" colspan="1">1.00</td>
                          <td align="center" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">    1</td>
                          <td align="center" rowspan="1" colspan="1">0.68 (0.46–1.02)</td>
                          <td align="center" rowspan="1" colspan="1">0.063</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">    ≥2</td>
                          <td align="center" rowspan="1" colspan="1">0.81 (0.54–1.20)</td>
                          <td align="center" rowspan="1" colspan="1">0.288</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">    Unknown</td>
                          <td align="center" rowspan="1" colspan="1">1.12 (0.56–2.24)</td>
                          <td align="center" rowspan="1" colspan="1">0.740</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>Type of insurance coverage</bold>
                          </td>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">    Medicaid</td>
                          <td align="center" rowspan="1" colspan="1">1.00</td>
                          <td align="center" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">    Private</td>
                          <td align="center" rowspan="1" colspan="1">1.57 (0.95–2.58)</td>
                          <td align="center" rowspan="1" colspan="1">0.076</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">    Medicare/Medicaid</td>
                          <td align="center" rowspan="1" colspan="1">1.66 (1.06–2.60)</td>
                          <td align="center" rowspan="1" colspan="1">0.028</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">    Medicare</td>
                          <td align="center" rowspan="1" colspan="1">1.68 (1.03–2.75)</td>
                          <td align="center" rowspan="1" colspan="1">0.039</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>Region</bold>
                          </td>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">    Metro-North</td>
                          <td align="center" rowspan="1" colspan="1">1.00</td>
                          <td align="center" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">    San Juan</td>
                          <td align="center" rowspan="1" colspan="1">0.95 (0.52–1.71)</td>
                          <td align="center" rowspan="1" colspan="1">0.853</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">    East</td>
                          <td align="center" rowspan="1" colspan="1">1.45 (0.85–2.49)</td>
                          <td align="center" rowspan="1" colspan="1">0.176</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">    North</td>
                          <td align="center" rowspan="1" colspan="1">1.32 (0.73–2.37)</td>
                          <td align="center" rowspan="1" colspan="1">0.358</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">    Northeast</td>
                          <td align="center" rowspan="1" colspan="1">0.58 (0.34–0.99)</td>
                          <td align="center" rowspan="1" colspan="1">0.046</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">    Southeast</td>
                          <td align="center" rowspan="1" colspan="1">1.03 (0.56–1.90)</td>
                          <td align="center" rowspan="1" colspan="1">0.912</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">    Southwest</td>
                          <td align="center" rowspan="1" colspan="1">1.43 (0.7–2.94)</td>
                          <td align="center" rowspan="1" colspan="1">0.325</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">    West</td>
                          <td align="center" rowspan="1" colspan="1">1.01 (0.6–1.71)</td>
                          <td align="center" rowspan="1" colspan="1">0.959</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>Primary tumor location</bold>
                          </td>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">    Distal</td>
                          <td align="center" rowspan="1" colspan="1">1.00</td>
                          <td align="center" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">    Proximal</td>
                          <td align="center" rowspan="1" colspan="1">0.95 (0.69–1.31)</td>
                          <td align="center" rowspan="1" colspan="1">0.744</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">    Other</td>
                          <td align="center" rowspan="1" colspan="1">0.46 (0.11–1.84)</td>
                          <td align="center" rowspan="1" colspan="1">0.269</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">
                            <bold>Tumor grade</bold>
                          </td>
                          <td align="center" rowspan="1" colspan="1"/>
                          <td align="center" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">    Well/moderately differentiated</td>
                          <td align="center" rowspan="1" colspan="1">1.00</td>
                          <td align="center" rowspan="1" colspan="1"/>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">    Poorly/undifferentiated</td>
                          <td align="center" rowspan="1" colspan="1">0.74 (0.46–1.16)</td>
                          <td align="center" rowspan="1" colspan="1">0.190</td>
                        </tr>
                        <tr>
                          <td align="left" rowspan="1" colspan="1">    Unknown</td>
                          <td align="center" rowspan="1" colspan="1">1.07 (0.61–1.89)</td>
                          <td align="center" rowspan="1" colspan="1">0.804</td>
                        </tr>
                      </tbody>
                    </table>
                  </alternatives>
                </table-wrap>
                <sec id="sec015">
                  <title>Use of oxaliplatin</title>
                  <p>Results from the multivariate logistic model for oxaliplatin use are shown in <xref ref-type="table" rid="pone.0194415.t005">Table 5</xref>. Compared with patients aged &lt;60 years, patients aged ≥70 years were less likely to receive oxaliplatin (AOR: 0.45; 95%CI: 0.26–0.78; p = 0.005); whereas, patients diagnosed after 2008 were more likely to receive oxaliplatin (p&lt;0.05). No significant associations were observed with marital status, CCI, type of insurance coverage, primary tumor location, and tumor grade.</p>
                  <table-wrap id="pone.0194415.t005" orientation="portrait" position="float">
                    <object-id pub-id-type="doi">10.1371/journal.pone.0194415.t005</object-id>
                    <label>Table 5</label>
                    <caption>
                      <title>Predictors of Receipt oxaliplatin.</title>
                    </caption>
                    <alternatives>
                      <graphic id="pone.0194415.t005g" xlink:href="pone.0194415.t005"/>
                      <table frame="hsides" rules="groups">
                        <colgroup span="1">
                          <col align="left" valign="middle" span="1"/>
                          <col align="left" valign="middle" span="1"/>
                          <col align="left" valign="middle" span="1"/>
                        </colgroup>
                        <thead>
                          <tr>
                            <th align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1">Characteristics</th>
                            <th align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1">AOR (95% CI)</th>
                            <th align="center" style="background-color:#D9D9D9" rowspan="1" colspan="1">P-value</th>
                          </tr>
                        </thead>
                        <tbody>
                          <tr>
                            <td align="left" rowspan="1" colspan="1">
                              <bold>Age group (years)</bold>
                            </td>
                            <td align="center" rowspan="1" colspan="1"/>
                            <td align="center" rowspan="1" colspan="1"/>
                          </tr>
                          <tr>
                            <td align="left" rowspan="1" colspan="1">    &lt;60</td>
                            <td align="center" rowspan="1" colspan="1">1.00</td>
                            <td align="center" rowspan="1" colspan="1"/>
                          </tr>
                          <tr>
                            <td align="left" rowspan="1" colspan="1">    60–69</td>
                            <td align="center" rowspan="1" colspan="1">1.03 (0.62–1.71)</td>
                            <td align="center" rowspan="1" colspan="1">0.921</td>
                          </tr>
                          <tr>
                            <td align="left" rowspan="1" colspan="1">    70+</td>
                            <td align="center" rowspan="1" colspan="1">0.45 (0.26–0.78)</td>
                            <td align="center" rowspan="1" colspan="1">0.005</td>
                          </tr>
                          <tr>
                            <td align="left" rowspan="1" colspan="1">
                              <bold>Marital status</bold>
                            </td>
                            <td align="center" rowspan="1" colspan="1"/>
                            <td align="center" rowspan="1" colspan="1"/>
                          </tr>
                          <tr>
                            <td align="left" rowspan="1" colspan="1">    Unmarried</td>
                            <td align="center" rowspan="1" colspan="1">1.00</td>
                            <td align="center" rowspan="1" colspan="1"/>
                          </tr>
                          <tr>
                            <td align="left" rowspan="1" colspan="1">    Married</td>
                            <td align="center" rowspan="1" colspan="1">1.14 (0.78–1.67)</td>
                            <td align="center" rowspan="1" colspan="1">0.493</td>
                          </tr>
                          <tr>
                            <td align="left" rowspan="1" colspan="1">    Unknown</td>
                            <td align="center" rowspan="1" colspan="1">0.53 (0.27–1.07)</td>
                            <td align="center" rowspan="1" colspan="1">0.078</td>
                          </tr>
                          <tr>
                            <td align="left" rowspan="1" colspan="1">
                              <bold>CCI</bold>
                            </td>
                            <td align="center" rowspan="1" colspan="1"/>
                            <td align="center" rowspan="1" colspan="1"/>
                          </tr>
                          <tr>
                            <td align="left" rowspan="1" colspan="1">    0</td>
                            <td align="center" rowspan="1" colspan="1">1.00</td>
                            <td align="center" rowspan="1" colspan="1"/>
                          </tr>
                          <tr>
                            <td align="left" rowspan="1" colspan="1">    1</td>
                            <td align="center" rowspan="1" colspan="1">1.29 (0.79–2.13)</td>
                            <td align="center" rowspan="1" colspan="1">0.311</td>
                          </tr>
                          <tr>
                            <td align="left" rowspan="1" colspan="1">    ≥2</td>
                            <td align="center" rowspan="1" colspan="1">0.84 (0.53–1.35)</td>
                            <td align="center" rowspan="1" colspan="1">0.482</td>
                          </tr>
                          <tr>
                            <td align="left" rowspan="1" colspan="1">    Unknown</td>
                            <td align="center" rowspan="1" colspan="1">1.36 (0.63–2.96)</td>
                            <td align="center" rowspan="1" colspan="1">0.432</td>
                          </tr>
                          <tr>
                            <td align="left" rowspan="1" colspan="1">
                              <bold>Type of insurance coverage</bold>
                            </td>
                            <td align="center" rowspan="1" colspan="1"/>
                            <td align="center" rowspan="1" colspan="1"/>
                          </tr>
                          <tr>
                            <td align="left" rowspan="1" colspan="1">    Medicaid</td>
                            <td align="center" rowspan="1" colspan="1">1.00</td>
                            <td align="center" rowspan="1" colspan="1"/>
                          </tr>
                          <tr>
                            <td align="left" rowspan="1" colspan="1">    Private</td>
                            <td align="center" rowspan="1" colspan="1">1.51 (0.87–2.63)</td>
                            <td align="center" rowspan="1" colspan="1">0.147</td>
                          </tr>
                          <tr>
                            <td align="left" rowspan="1" colspan="1">    Medicare/Medicaid</td>
                            <td align="center" rowspan="1" colspan="1">0.81 (0.48–1.37)</td>
                            <td align="center" rowspan="1" colspan="1">0.433</td>
                          </tr>
                          <tr>
                            <td align="left" rowspan="1" colspan="1">    Medicare</td>
                            <td align="center" rowspan="1" colspan="1">0.63 (0.35–1.12)</td>
                            <td align="center" rowspan="1" colspan="1">0.114</td>
                          </tr>
                          <tr>
                            <td align="left" rowspan="1" colspan="1">
                              <bold>Diagnosis year</bold>
                            </td>
                            <td align="center" rowspan="1" colspan="1"/>
                            <td align="center" rowspan="1" colspan="1"/>
                          </tr>
                          <tr>
                            <td align="left" rowspan="1" colspan="1">    2008</td>
                            <td align="center" rowspan="1" colspan="1">1.00</td>
                            <td align="center" rowspan="1" colspan="1"/>
                          </tr>
                          <tr>
                            <td align="left" rowspan="1" colspan="1">    2009</td>
                            <td align="center" rowspan="1" colspan="1">1.99 (1.15–3.47)</td>
                            <td align="center" rowspan="1" colspan="1">0.015</td>
                          </tr>
                          <tr>
                            <td align="left" rowspan="1" colspan="1">    2010</td>
                            <td align="center" rowspan="1" colspan="1">2.29 (1.32–3.95)</td>
                            <td align="center" rowspan="1" colspan="1">0.003</td>
                          </tr>
                          <tr>
                            <td align="left" rowspan="1" colspan="1">    2011</td>
                            <td align="center" rowspan="1" colspan="1">1.81 (1.05–3.11)</td>
                            <td align="center" rowspan="1" colspan="1">0.031</td>
                          </tr>
                          <tr>
                            <td align="left" rowspan="1" colspan="1">    2012</td>
                            <td align="center" rowspan="1" colspan="1">3.11 (1.74–5.55)</td>
                            <td align="center" rowspan="1" colspan="1">&lt;0.0001</td>
                          </tr>
                          <tr>
                            <td align="left" rowspan="1" colspan="1">
                              <bold>Primary tumor location</bold>
                            </td>
                            <td align="center" rowspan="1" colspan="1"/>
                            <td align="center" rowspan="1" colspan="1"/>
                          </tr>
                          <tr>
                            <td align="left" rowspan="1" colspan="1">    Distal</td>
                            <td align="center" rowspan="1" colspan="1">1.00</td>
                            <td align="center" rowspan="1" colspan="1"/>
                          </tr>
                          <tr>
                            <td align="left" rowspan="1" colspan="1">    Proximal</td>
                            <td align="center" rowspan="1" colspan="1">0.91 (0.63–1.32)</td>
                            <td align="center" rowspan="1" colspan="1">0.634</td>
                          </tr>
                          <tr>
                            <td align="left" rowspan="1" colspan="1">    Other</td>
                            <td align="center" rowspan="1" colspan="1"/>
                            <td align="center" rowspan="1" colspan="1"/>
                          </tr>
                          <tr>
                            <td align="left" rowspan="1" colspan="1">
                              <bold>Tumor grade</bold>
                            </td>
                            <td align="center" rowspan="1" colspan="1"/>
                            <td align="center" rowspan="1" colspan="1"/>
                          </tr>
                          <tr>
                            <td align="left" rowspan="1" colspan="1">    Well/moderately differentiated</td>
                            <td align="center" rowspan="1" colspan="1">1.00</td>
                            <td align="left" rowspan="1" colspan="1">    </td>
                          </tr>
                          <tr>
                            <td align="left" rowspan="1" colspan="1">    Poorly/undifferentiated</td>
                            <td align="center" rowspan="1" colspan="1">1.68 (0.89–3.16)</td>
                            <td align="center" rowspan="1" colspan="1">0.107</td>
                          </tr>
                          <tr>
                            <td align="left" rowspan="1" colspan="1">    Unknown</td>
                            <td align="center" rowspan="1" colspan="1">0.62 (0.33–1.15)</td>
                            <td align="center" rowspan="1" colspan="1">0.131</td>
                          </tr>
                        </tbody>
                      </table>
                    </alternatives>
                  </table-wrap>
                </sec>
              </sec>
              <sec id="sec016">
                <title>Overall survival by age group</title>
                <p><xref ref-type="fig" rid="pone.0194415.g001">Fig 1</xref> shows the effect of ACT on 3-year overall survival stratified by age-group (&lt;70 years and ≥70 years). For both age groups the overall 3-year survival was statistically higher (Log Rank Test p&lt;0.05) among ACT treated patients (patients aged &lt;70 years: 75% vs. 48%; patients aged ≥70: 63% vs. 43%, respectively). For both age-groups, patients treated with ACT had significantly lower risk of dying (aged&lt;70 years: HR: 0.43; 95% CI: 0.30–0.61; p&lt;0.001; and aged ≥70 years: HR: 0.51; 95% CI: 0.38–0.69; p&lt;0.001).</p>
                <fig id="pone.0194415.g001" orientation="portrait" position="float">
                  <object-id pub-id-type="doi">10.1371/journal.pone.0194415.g001</object-id>
                  <label>Fig 1</label>
                  <caption>
                    <title>Three-year overall survival according to the Receipt of ACT stratified by age group (&lt;70 years and ≥70 years) ACT = adjuvant chemotherapy.</title>
                  </caption>
                  <graphic xlink:href="pone.0194415.g001"/>
                </fig>
                <p>Use of oxaliplatin showed a survival benefit only among patients aged &lt;70 years (77% vs. 63%; Rank test p&lt;0.05) but not among patients aged ≥70 years (66% vs. 58%; Log Rank test p = 0.2). Patients aged &lt;70 years receiving oxaliplatin had a significant lower risk of dying (HR: 0.50; 95% CI: 0.33–0.75; p = 0.001); whereas, no statistical significance difference was achieved among patients aged ≥70 years (HR: 0.78; 95% CI: 0.50–1.22; p = 0.279) (<xref ref-type="fig" rid="pone.0194415.g002">Fig 2</xref>).</p>
                <fig id="pone.0194415.g002" orientation="portrait" position="float">
                  <object-id pub-id-type="doi">10.1371/journal.pone.0194415.g002</object-id>
                  <label>Fig 2</label>
                  <caption>
                    <title>Three-year overall survival according to the Receipt of oxaliplatin among patients receiving ACT by age group (&lt;70 years and ≥70 years).</title>
                  </caption>
                  <graphic xlink:href="pone.0194415.g002"/>
                </fig>
              </sec>
            </sec>
            <sec sec-type="conclusions" id="sec017">
              <title>Discussion</title>
              <p>Understanding the pattern of care and barriers for the use of evidence-based guidelines is important to increase access to quality care, improve health outcomes, and reduce health disparities. This study examines, for the first time, the patterns of use of ACT and oxaliplatin for stage III colon cancer in Puerto Rico, the factors associated with the use of these guideline-recommended treatments in the island, and their impact on 3-year overall survival and risk of death. The results of this study can help to improve the quality of care for stage III colon cancer and address disparities in cancer care delivery and health outcomes.</p>
              <p>Overall, 75% of the study population received ACT. Although comparable with previous population based studies, the percentage patients receiving ACT was higher than the reported in recent studies [<xref rid="pone.0194415.ref002" ref-type="bibr">2</xref>,<xref rid="pone.0194415.ref004" ref-type="bibr">4</xref>,<xref rid="pone.0194415.ref010" ref-type="bibr">10</xref>,<xref rid="pone.0194415.ref015" ref-type="bibr">15</xref>,<xref rid="pone.0194415.ref019" ref-type="bibr">19</xref>,<xref rid="pone.0194415.ref020" ref-type="bibr">20</xref>]. This difference might be attributable to the high health insurance coverage in Puerto Rico (96.3%) [<xref rid="pone.0194415.ref026" ref-type="bibr">26</xref>] and the adherence of health professionals in Puerto Rico to evidence-based treatment guidelines recommended. A recent study comparing coverage and access to care in Puerto Rico and the mainland US found that, despite the economic conditions in Puerto Rico, it has better coverage and access to care indicators [<xref rid="pone.0194415.ref027" ref-type="bibr">27</xref>]. The authors of this study also point out that these results are consistent with the fact that states with more unrestrictive Medicaid eligibility have better access to care [<xref rid="pone.0194415.ref027" ref-type="bibr">27</xref>]. On the other hand, this difference might also be explained by differences in data source, study population, and period of observation.</p>
              <p>Consistent with previous studies [<xref rid="pone.0194415.ref002" ref-type="bibr">2</xref>–<xref rid="pone.0194415.ref004" ref-type="bibr">4</xref>,<xref rid="pone.0194415.ref010" ref-type="bibr">10</xref>,<xref rid="pone.0194415.ref016" ref-type="bibr">16</xref>,<xref rid="pone.0194415.ref028" ref-type="bibr">28</xref>–<xref rid="pone.0194415.ref030" ref-type="bibr">30</xref>], our data showed that patients with stage III colon cancer receiving ACT had a statistically significant reduction in mortality compared with those no receiving ACT. Our data also showed that patients aged ≥70 years, Medicaid enrollees, unmarried patients, and patients who resided in the northeast region of the Island at the time of diagnosis were less likely to receive ACT. Patients’ age has been previously reported to be a strong predictor for no receiving ACT [<xref rid="pone.0194415.ref010" ref-type="bibr">10</xref>,<xref rid="pone.0194415.ref015" ref-type="bibr">15</xref>,<xref rid="pone.0194415.ref016" ref-type="bibr">16</xref>,<xref rid="pone.0194415.ref019" ref-type="bibr">19</xref>–<xref rid="pone.0194415.ref021" ref-type="bibr">21</xref>,<xref rid="pone.0194415.ref031" ref-type="bibr">31</xref>], despite the fact that several studies, including the present study, have shown a benefit of ACT in older patients [<xref rid="pone.0194415.ref002" ref-type="bibr">2</xref>–<xref rid="pone.0194415.ref004" ref-type="bibr">4</xref>,<xref rid="pone.0194415.ref016" ref-type="bibr">16</xref>,<xref rid="pone.0194415.ref032" ref-type="bibr">32</xref>,<xref rid="pone.0194415.ref033" ref-type="bibr">33</xref>]. Patients aged ≥70 years who received ACT had better survival and lower risk of death compared to those no receiving ACT.</p>
              <p>Compared to patients enrolled in Medicaid, those enrolled in Medicare and dual Medicaid and Medicare were more likely to receive ACT. These findings are consistent with previous studies [<xref rid="pone.0194415.ref010" ref-type="bibr">10</xref>,<xref rid="pone.0194415.ref030" ref-type="bibr">30</xref>,<xref rid="pone.0194415.ref034" ref-type="bibr">34</xref>] and with studies conducted in Puerto Rico [<xref rid="pone.0194415.ref035" ref-type="bibr">35</xref>–<xref rid="pone.0194415.ref038" ref-type="bibr">38</xref>]. Our group showed that cancer patients enrolled in the Puerto Rico’s Government Health Plan have poorer health outcomes and less access to guideline-recommended treatment compared to those enrolled in other health insurances coverage [<xref rid="pone.0194415.ref035" ref-type="bibr">35</xref>–<xref rid="pone.0194415.ref038" ref-type="bibr">38</xref>]. Even when Puerto Rico has a high insurance coverage, the fact that Medicaid patients are less likely to receive ACT could suggest that Medicaid patients may not be receiving guideline-recommended treatment for stage III colon cancer. It has been suggested that other unmeasured socioeconomic characteristics may partially explain the observed differences found in cancer care delivery for stage III colon cancer [<xref rid="pone.0194415.ref038" ref-type="bibr">38</xref>].</p>
              <p>Similar to previous studies [<xref rid="pone.0194415.ref011" ref-type="bibr">11</xref>,<xref rid="pone.0194415.ref017" ref-type="bibr">17</xref>,<xref rid="pone.0194415.ref019" ref-type="bibr">19</xref>], we found that patients diagnosed in later years were more likely to receive oxaliplatin. In fact, when we stratified by age groups we observed the same pattern (data not shown). This finding could be attributable to the progressively adoption of oxaliplatin as a part of adjuvant chemotherapy among clinicians. In 2004, oxaliplatin was approved for use in patients with stage III colon cancer. After this event, the oxaliplatin-based regimens became the preferred ACT regimens for patients with resected stage III colon cancer [<xref rid="pone.0194415.ref011" ref-type="bibr">11</xref>,<xref rid="pone.0194415.ref017" ref-type="bibr">17</xref>,<xref rid="pone.0194415.ref019" ref-type="bibr">19</xref>,<xref rid="pone.0194415.ref039" ref-type="bibr">39</xref>].Large population-based studies using SEER data found that unmarried patients are at significantly higher risk of presenting metastatic cancer, undertreatment, and death resulting from their cancer [<xref rid="pone.0194415.ref040" ref-type="bibr">40</xref>–<xref rid="pone.0194415.ref042" ref-type="bibr">42</xref>]. Consistent with previous studies, our findings showed that unmarried patients had lower odds of receiving ACT compared to married patients. This association might be explained by other factors such as age, income, type of health insurance, and social support, among others. We also found that patients living in the Northeast region at the time of diagnosis were less likely to receive ACT. A plausible explanation of the underutilization of ACT in this region could be attributable to the access to treatment in the island-municipalities of Vieques and Culebra. Further analyses are warranted to asses possible factors associated with difference in geographic access to guideline-recommend treatment.</p>
              <p>There was not a statistically significant benefit of receiving oxaliplatin among patients aged ≥70 years (HR = 0.78; 95% CI: 0.50–1.22) compared to younger patients. As we expected, patients aged ≥70 years were less likely to receive oxaliplatin since current NCCN guidelines do not recommend its use in these patients. The use of oxaliplatin in this population should be evaluated taking into account the toxicity and the patient’s characteristics and preferences.</p>
              <p>The findings in this study are subject to some limitations. First, we limited our analysis to patients with health insurance coverage and that had claims data. Therefore, caution must be taken when generalizing these results. Second, due to the nature of claims data, as they are collected for reimbursement purposes, have inherent limitations when used in research studies. Third, we only evaluated the use of ACT if the patient had a claim with ACT, but we are not able to assess patient’s adherence to recommended treatment. Also, it is important to note that, by definition and according to guidelines, only those patients receiving ACT within four months after colon surgery were considered to have received ACT. Finally, another possible limitation is that we did not evaluate patient’s preferences. For example, we did not evaluate if the patient refused the chemotherapy treatment. Nevertheless, results of this study are consistent with other studies and confirms the viability of the use of the PRCCR-HILD database in cancer care delivery research.</p>
              <p>In conclusion, similar to other populations, we found that only 25% of the stage III colon cancer do not receive guideline-recommended treatment. In addition, consistent with previous studies, we identified disparities in the use of ACT in the Puerto Rico population that need to be addressed. Considering that combining men and women colorectal cancer is the leading cause of cancer death in Puerto Rico, this study raises the need for further assess the pattern of cancer treatment in the island, identify barriers to access guideline-recommend cancer treatment, and the development and implementation of effective multilevel interventions to reduce barriers to guideline-based recommended treatment for stage III colon cancer patients. This is particularly relevant given the economic and financial crisis in Puerto Rico and uncertainty in Medicaid funding that might leave thousands of patients without access to care. Furthermore, this problem will be compounded by the prevailing migration of healthcare professional to the U.S. mainland.</p>
            </sec>
            <sec sec-type="supplementary-material" id="sec018">
              <title>Supporting information</title>
              <supplementary-material content-type="local-data" id="pone.0194415.s001">
                <label>S1 Table</label>
                <caption>
                  <title>Treatment associated claims codes.</title>
                  <p>(PDF)</p>
                </caption>
                <media xlink:href="pone.0194415.s001.pdf">
                  <caption>
                    <p>Click here for additional data file.</p>
                  </caption>
                </media>
              </supplementary-material>
            </sec>
          </body>
          <back>
            <ref-list>
              <title>References</title>
              <ref id="pone.0194415.ref001">
                <label>1</label>
                <mixed-citation publication-type="journal"><name><surname>Benson</surname><given-names>AB</given-names><suffix>III</suffix></name>, <name><surname>Venook</surname><given-names>AP</given-names></name>, <name><surname>Cederquist</surname><given-names>L</given-names></name>, <name><surname>Chan</surname><given-names>E</given-names></name>, <name><surname>Chen</surname><given-names>Y-J</given-names></name>, <name><surname>Cooper</surname><given-names>HS</given-names></name>, <etal>et al</etal><article-title>Colon Cancer, Version 1.2017 Clinical Practice Guidelines in Oncology</article-title>. <source>J Natl Compr CANCER Netw</source>. 37 MAIN ST, COLD SPRING HARBOR, NY 11724 USA: HARBORSIDE PRESS; <year>2017</year>;<volume>15</volume>: <fpage>370</fpage>–<lpage>398</lpage>.</mixed-citation>
              </ref>
              <ref id="pone.0194415.ref002">
                <label>2</label>
                <mixed-citation publication-type="journal"><name><surname>Merchant</surname><given-names>SJ</given-names></name>, <name><surname>Nanji</surname><given-names>S</given-names></name>, <name><surname>Brennan</surname><given-names>K</given-names></name>, <name><surname>Karim</surname><given-names>S</given-names></name>, <name><surname>Patel</surname><given-names>SV</given-names></name>, <name><surname>Biagi</surname><given-names>JJ</given-names></name>, <etal>et al</etal><article-title>Management of stage III colon cancer in the elderly: Practice patterns and outcomes in the general population</article-title>. <source>Cancer</source>. <year>2017</year>; <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1002/cncr.30691">10.1002/cncr.30691</ext-link></comment><?supplied-pmid 28346663?><pub-id pub-id-type="pmid">28346663</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0194415.ref003">
                <label>3</label>
                <mixed-citation publication-type="journal"><name><surname>Sanoff</surname><given-names>HK</given-names></name>, <name><surname>Carpenter</surname><given-names>WR</given-names></name>, <name><surname>Stürmer</surname><given-names>T</given-names></name>, <name><surname>Goldberg</surname><given-names>RM</given-names></name>, <name><surname>Martin</surname><given-names>CF</given-names></name>, <name><surname>Fine</surname><given-names>JP</given-names></name>, <etal>et al</etal><article-title>Effect of Adjuvant Chemotherapy on Survival of Patients With Stage III Colon Cancer Diagnosed After Age 75 Years</article-title>. <source>J Clin Oncol</source>. <year>2012</year>;<volume>30</volume>: <fpage>2624</fpage>–<lpage>2634</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1200/JCO.2011.41.1140">10.1200/JCO.2011.41.1140</ext-link></comment>
<?supplied-pmid 22665536?><pub-id pub-id-type="pmid">22665536</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0194415.ref004">
                <label>4</label>
                <mixed-citation publication-type="journal"><name><surname>Hines</surname><given-names>RB</given-names></name>, <name><surname>Bimali</surname><given-names>M</given-names></name>, <name><surname>Johnson</surname><given-names>AM</given-names></name>, <name><surname>Bayakly</surname><given-names>AR</given-names></name>, <name><surname>Collins</surname><given-names>TC</given-names></name>. <article-title>Prevalence and survival benefit of adjuvant chemotherapy in stage III colon cancer patients: Comparison of overall and age-stratified results by multivariable modeling and propensity score methodology in a population-based cohort</article-title>. <source>Cancer Epidemiol</source>. <year>2016</year>;<volume>44</volume>: <fpage>77</fpage>–<lpage>83</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.canep.2016.08.004">10.1016/j.canep.2016.08.004</ext-link></comment>
<?supplied-pmid 27513721?><pub-id pub-id-type="pmid">27513721</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0194415.ref005">
                <label>5</label>
                <mixed-citation publication-type="journal"><name><surname>Jeong</surname><given-names>WK</given-names></name>, <name><surname>Shin</surname><given-names>J-W</given-names></name>, <name><surname>Baek</surname><given-names>SK</given-names></name>. <article-title>Oncologic outcomes of early adjuvant chemotherapy initiation in patients with stage III colon cancer</article-title>. <source>Ann Surg Treat Res</source>. <year>2015</year>;<volume>89</volume>: <fpage>124</fpage>–<lpage>30</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.4174/astr.2015.89.3.124">10.4174/astr.2015.89.3.124</ext-link></comment>
<?supplied-pmid 26366381?><pub-id pub-id-type="pmid">26366381</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0194415.ref006">
                <label>6</label>
                <mixed-citation publication-type="journal"><name><surname>Hsiao</surname><given-names>F-Y</given-names></name>, <name><surname>Mullins</surname><given-names>CD</given-names></name>, <name><surname>Onukwugha</surname><given-names>E</given-names></name>, <name><surname>Pandya</surname><given-names>N</given-names></name>, <name><surname>Hanna</surname><given-names>N</given-names></name>. <article-title>Comparative Effectiveness of Different Chemotherapeutic Regimens on Survival of People Aged 66 and Older with Stage III Colon Cancer: A “Real World” Analysis Using Surveillance, Epidemiology, and End Results-Medicare Data</article-title>. <source>J Am Geriatr Soc</source>. <year>2011</year>;<volume>59</volume>: <fpage>1717</fpage>–<lpage>1723</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1111/j.1532-5415.2011.03501.x">10.1111/j.1532-5415.2011.03501.x</ext-link></comment>
<?supplied-pmid 21831168?><pub-id pub-id-type="pmid">21831168</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0194415.ref007">
                <label>7</label>
                <mixed-citation publication-type="journal"><name><surname>Zuckerman</surname><given-names>IH</given-names></name>, <name><surname>Rapp</surname><given-names>T</given-names></name>, <name><surname>Onukwugha</surname><given-names>E</given-names></name>, <name><surname>Davidoff</surname><given-names>A</given-names></name>, <name><surname>Choti</surname><given-names>MA</given-names></name>, <name><surname>Gardner</surname><given-names>J</given-names></name>, <etal>et al</etal><article-title>Effect of Age on Survival Benefit of Adjuvant Chemotherapy in Elderly Patients with Stage III Colon Cancer</article-title>. <source>J Am Geriatr Soc</source>. <year>2009</year>;<volume>57</volume>: <fpage>1403</fpage>–<lpage>1410</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1111/j.1532-5415.2009.02355.x">10.1111/j.1532-5415.2009.02355.x</ext-link></comment>
<?supplied-pmid 19563521?><pub-id pub-id-type="pmid">19563521</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0194415.ref008">
                <label>8</label>
                <mixed-citation publication-type="journal"><name><surname>André</surname><given-names>T</given-names></name>, <name><surname>Boni</surname><given-names>C</given-names></name>, <name><surname>Navarro</surname><given-names>M</given-names></name>, <name><surname>Tabernero</surname><given-names>J</given-names></name>, <name><surname>Hickish</surname><given-names>T</given-names></name>, <name><surname>Topham</surname><given-names>C</given-names></name>, <etal>et al</etal><article-title>Improved overall survival with oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment in stage II or III colon cancer in the MOSAIC trial</article-title>. <source>J Clin Oncol</source>. <year>2009</year>;<volume>27</volume>: <fpage>3109</fpage>–<lpage>16</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1200/JCO.2008.20.6771">10.1200/JCO.2008.20.6771</ext-link></comment>
<?supplied-pmid 19451431?><pub-id pub-id-type="pmid">19451431</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0194415.ref009">
                <label>9</label>
                <mixed-citation publication-type="journal"><name><surname>André</surname><given-names>T</given-names></name>, <name><surname>Boni</surname><given-names>C</given-names></name>, <name><surname>Mounedji-Boudiaf</surname><given-names>L</given-names></name>, <name><surname>Navarro</surname><given-names>M</given-names></name>, <name><surname>Tabernero</surname><given-names>J</given-names></name>, <name><surname>Hickish</surname><given-names>T</given-names></name>, <etal>et al</etal><article-title>Oxaliplatin, fluorouracil, and leucovorin as adjuvant treatment for colon cancer</article-title>. <source>N Engl J Med</source>. <year>2004</year>;<volume>350</volume>: <fpage>2343</fpage>–<lpage>51</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1056/NEJMoa032709">10.1056/NEJMoa032709</ext-link></comment>
<?supplied-pmid 15175436?><pub-id pub-id-type="pmid">15175436</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0194415.ref010">
                <label>10</label>
                <mixed-citation publication-type="journal"><name><surname>Becerra</surname><given-names>AZ</given-names></name>, <name><surname>Probst</surname><given-names>CP</given-names></name>, <name><surname>Tejani</surname><given-names>MA</given-names></name>, <name><surname>Aquina</surname><given-names>CT</given-names></name>, <name><surname>González</surname><given-names>MG</given-names></name>, <name><surname>Hensley</surname><given-names>BJ</given-names></name>, <etal>et al</etal><article-title>Opportunity lost: Adjuvant chemotherapy in patients with stage III colon cancer remains underused</article-title>. <source>Surgery</source>. <year>2015</year>;<volume>158</volume>: <fpage>692</fpage>–<lpage>9</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.surg.2015.03.057">10.1016/j.surg.2015.03.057</ext-link></comment>
<?supplied-pmid 26032822?><pub-id pub-id-type="pmid">26032822</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0194415.ref011">
                <label>11</label>
                <mixed-citation publication-type="journal"><name><surname>Sanoff</surname><given-names>HK</given-names></name>, <name><surname>Carpenter</surname><given-names>WR</given-names></name>, <name><surname>Martin</surname><given-names>CF</given-names></name>, <name><surname>Sargent</surname><given-names>DJ</given-names></name>, <name><surname>Meyerhardt</surname><given-names>JA</given-names></name>, <name><surname>Stürmer</surname><given-names>T</given-names></name>, <etal>et al</etal><article-title>Comparative Effectiveness of Oxaliplatin vs Non–Oxaliplatin-containing Adjuvant Chemotherapy for Stage III Colon Cancer</article-title>. <source>JNCI J Natl Cancer Inst</source>. <year>2012</year>;<volume>104</volume>: <fpage>211</fpage>–<lpage>227</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1093/jnci/djr524">10.1093/jnci/djr524</ext-link></comment>
<?supplied-pmid 22266473?><pub-id pub-id-type="pmid">22266473</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0194415.ref012">
                <label>12</label>
                <mixed-citation publication-type="journal"><name><surname>Yothers</surname><given-names>G</given-names></name>, <name><surname>O’Connell</surname><given-names>MJ</given-names></name>, <name><surname>Allegra</surname><given-names>CJ</given-names></name>, <name><surname>Kuebler</surname><given-names>JP</given-names></name>, <name><surname>Colangelo</surname><given-names>LH</given-names></name>, <name><surname>Petrelli</surname><given-names>NJ</given-names></name>, <etal>et al</etal><article-title>Oxaliplatin As Adjuvant Therapy for Colon Cancer: Updated Results of NSABP C-07 Trial, Including Survival and Subset Analyses</article-title>. <source>J Clin Oncol</source>. <year>2011</year>;<volume>29</volume>: <fpage>3768</fpage>–<lpage>3774</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1200/JCO.2011.36.4539">10.1200/JCO.2011.36.4539</ext-link></comment>
<?supplied-pmid 21859995?><pub-id pub-id-type="pmid">21859995</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0194415.ref013">
                <label>13</label>
                <mixed-citation publication-type="journal"><name><surname>Schmoll</surname><given-names>H-J</given-names></name>, <name><surname>Twelves</surname><given-names>C</given-names></name>, <name><surname>Sun</surname><given-names>W</given-names></name>, <name><surname>O’Connell</surname><given-names>MJ</given-names></name>, <name><surname>Cartwright</surname><given-names>T</given-names></name>, <name><surname>McKenna</surname><given-names>E</given-names></name>, <etal>et al</etal><article-title>Effect of adjuvant capecitabine or fluorouracil, with or without oxaliplatin, on survival outcomes in stage III colon cancer and the effect of oxaliplatin on post-relapse survival: a pooled analysis of individual patient data from four randomised controlled trials</article-title>. <source>Lancet Oncol</source>. <year>2014</year>;<volume>15</volume>: <fpage>1481</fpage>–<lpage>1492</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/S1470-2045(14)70486-3">10.1016/S1470-2045(14)70486-3</ext-link></comment>
<?supplied-pmid 25456367?><pub-id pub-id-type="pmid">25456367</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0194415.ref014">
                <label>14</label>
                <mixed-citation publication-type="journal"><name><surname>van Erning</surname><given-names>FN</given-names></name>, <name><surname>Janssen-Heijnen</surname><given-names>MLG</given-names></name>, <name><surname>Creemers</surname><given-names>GJ</given-names></name>, <name><surname>Pruijt</surname><given-names>JFM</given-names></name>, <article-title>Maas HAAM, Lemmens VEPP. Recurrence-free and overall survival among elderly stage III colon cancer patients treated with CAPOX or capecitabine monotherapy</article-title>. <source>Int J cancer</source>. <year>2017</year>;<volume>140</volume>: <fpage>224</fpage>–<lpage>233</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1002/ijc.30423">10.1002/ijc.30423</ext-link></comment>
<?supplied-pmid 27615021?><pub-id pub-id-type="pmid">27615021</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0194415.ref015">
                <label>15</label>
                <mixed-citation publication-type="journal"><name><surname>Murphy</surname><given-names>CC</given-names></name>, <name><surname>Harlan</surname><given-names>LC</given-names></name>, <name><surname>Warren</surname><given-names>JL</given-names></name>, <name><surname>Geiger</surname><given-names>AM</given-names></name>. <article-title>Race and Insurance Differences in the Receipt of Adjuvant Chemotherapy Among Patients With Stage III Colon Cancer</article-title>. <source>J Clin Oncol</source>. <year>2015</year>;<volume>33</volume>: <fpage>2530</fpage>–<lpage>6</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1200/JCO.2015.61.3026">10.1200/JCO.2015.61.3026</ext-link></comment>
<?supplied-pmid 26150445?><pub-id pub-id-type="pmid">26150445</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0194415.ref016">
                <label>16</label>
                <mixed-citation publication-type="journal"><name><surname>Abraham</surname><given-names>A</given-names></name>, <name><surname>Habermann</surname><given-names>EB</given-names></name>, <name><surname>Rothenberger</surname><given-names>DA</given-names></name>, <name><surname>Kwaan</surname><given-names>M</given-names></name>, <name><surname>Weinberg</surname><given-names>AD</given-names></name>, <name><surname>Parsons</surname><given-names>HM</given-names></name>, <etal>et al</etal><article-title>Adjuvant chemotherapy for stage III colon cancer in the oldest old</article-title>. <source>Cancer</source>. Wiley Subscription Services, Inc., A Wiley Company; <year>2013</year>;<volume>119</volume>: <fpage>395</fpage>–<lpage>403</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1002/cncr.27755">10.1002/cncr.27755</ext-link></comment>
<?supplied-pmid 22806931?><pub-id pub-id-type="pmid">22806931</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0194415.ref017">
                <label>17</label>
                <mixed-citation publication-type="journal"><name><surname>Lund</surname><given-names>JL</given-names></name>, <name><surname>Stürmer</surname><given-names>T</given-names></name>, <name><surname>Sanoff</surname><given-names>HK</given-names></name>, <name><surname>Brookhart</surname><given-names>A</given-names></name>, <name><surname>Sandler</surname><given-names>RS</given-names></name>, <name><surname>Warren</surname><given-names>JL</given-names></name>. <article-title>Determinants of adjuvant oxaliplatin receipt among older stage II and III colorectal cancer patients</article-title>. <source>Cancer</source>. <year>2013</year>;<volume>119</volume>: <fpage>2038</fpage>–<lpage>47</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1002/cncr.27991">10.1002/cncr.27991</ext-link></comment>
<?supplied-pmid 23512326?><pub-id pub-id-type="pmid">23512326</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0194415.ref018">
                <label>18</label>
                <mixed-citation publication-type="journal"><name><surname>Lin</surname><given-names>CC</given-names></name>, <name><surname>Bruinooge</surname><given-names>SS</given-names></name>, <name><surname>Kirkwood</surname><given-names>MK</given-names></name>, <name><surname>Olsen</surname><given-names>C</given-names></name>, <name><surname>Jemal</surname><given-names>A</given-names></name>, <name><surname>Bajorin</surname><given-names>D</given-names></name>, <etal>et al</etal><article-title>Association Between Geographic Access to Cancer Care, Insurance, and Receipt of Chemotherapy: Geographic Distribution of Oncologists and Travel Distance</article-title>. <source>J Clin Oncol</source>. <year>2015</year>; <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1200/JCO.2015.61.1558">10.1200/JCO.2015.61.1558</ext-link></comment><?supplied-pmid 26304878?><pub-id pub-id-type="pmid">26304878</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0194415.ref019">
                <label>19</label>
                <mixed-citation publication-type="journal"><name><surname>Panchal</surname><given-names>JM</given-names></name>, <name><surname>Lairson</surname><given-names>DR</given-names></name>, <name><surname>Chan</surname><given-names>W</given-names></name>, <name><surname>Du</surname><given-names>XL</given-names></name>. <article-title>Geographic Variation and Sociodemographic Disparity in the Use of Oxaliplatin-Containing Chemotherapy in Patients With Stage III Colon Cancer</article-title>. <source>Clin Colorectal Cancer</source>. <year>2013</year>;<volume>12</volume>: <fpage>113</fpage>–<lpage>121</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1016/j.clcc.2012.09.007">10.1016/j.clcc.2012.09.007</ext-link></comment>
<?supplied-pmid 23137529?><pub-id pub-id-type="pmid">23137529</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0194415.ref020">
                <label>20</label>
                <mixed-citation publication-type="journal"><name><surname>Hsieh</surname><given-names>M-C</given-names></name>, <name><surname>Chiu</surname><given-names>Y-W</given-names></name>, <name><surname>Velasco</surname><given-names>C</given-names></name>, <name><surname>Wu</surname><given-names>X-C</given-names></name>, <name><surname>O’Flarity</surname><given-names>MB</given-names></name>, <name><surname>Chen</surname><given-names>VW</given-names></name>. <article-title>Impact of race/ethnicity and socioeconomic status on adjuvant chemotherapy use among elderly patients with stage III colon cancer</article-title>. <source>J Registry Manag</source>. <year>2013</year>;<volume>40</volume>: <fpage>180</fpage>–<lpage>7</lpage>. Available: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/24625772">http://www.ncbi.nlm.nih.gov/pubmed/24625772</ext-link>
<?supplied-pmid 24625772?><pub-id pub-id-type="pmid">24625772</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0194415.ref021">
                <label>21</label>
                <mixed-citation publication-type="journal"><name><surname>HA</surname><given-names>GS</given-names></name>, <name><surname>KIM</surname><given-names>YW</given-names></name>, <name><surname>CHOI</surname><given-names>EH</given-names></name>, <name><surname>KIM</surname><given-names>IY</given-names></name>. <article-title>Factors Associated with the Lack of Adjuvant Chemotherapy Following Curative Surgery for Stage II and III Colon Cancer: A Korean National Cohort Study</article-title>. <source>Anticancer Res</source>. <year>2017</year>;<volume>37</volume>: <fpage>915</fpage>–<lpage>922</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.21873/anticanres.11399">10.21873/anticanres.11399</ext-link></comment>
<?supplied-pmid 28179352?><pub-id pub-id-type="pmid">28179352</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0194415.ref022">
                <label>22</label>
                <mixed-citation publication-type="other">Kaiser Family Foundation. Health Insurance Coverage of the Population in Puerto Rico and the 50 States and D.C., 2014 (based on the Census Bureau’s 2014 American Community Survey, 1-year estimates). In: 8 Questions &amp; Answers about Puerto Rico [Internet]. 2016 [cited 22 Aug 2017]. Available: <ext-link ext-link-type="uri" xlink:href="http://www.kff.org/disparities-policy/fact-sheet/8-questions-and-answers-about-puerto-rico/">http://www.kff.org/disparities-policy/fact-sheet/8-questions-and-answers-about-puerto-rico/</ext-link></mixed-citation>
              </ref>
              <ref id="pone.0194415.ref023">
                <label>23</label>
                <mixed-citation publication-type="journal"><name><surname>Ortiz-Ortiz</surname><given-names>KJ</given-names></name>, <name><surname>Ramírez-García</surname><given-names>R</given-names></name>, <name><surname>Cruz-Correa</surname><given-names>M</given-names></name>, <name><surname>Ríos-González</surname><given-names>MY</given-names></name>, <name><surname>Ortiz</surname><given-names>AP</given-names></name>. <article-title>Effects of type of health insurance coverage on colorectal cancer survival in Puerto Rico: A population-based study</article-title>. <source>PLoS One</source>. Public Library of Science; <year>2014</year>;<volume>9</volume>.</mixed-citation>
              </ref>
              <ref id="pone.0194415.ref024">
                <label>24</label>
                <mixed-citation publication-type="journal"><name><surname>Potosky</surname><given-names>AL</given-names></name>, <name><surname>Riley</surname><given-names>GF</given-names></name>, <name><surname>Lubitz</surname><given-names>JD</given-names></name>, <name><surname>Mentnech</surname><given-names>RM</given-names></name>, <name><surname>Kessler</surname><given-names>LG</given-names></name>. <article-title>Potential for cancer related health services research using a linked Medicare-tumor registry database</article-title>. <source>Med Care</source>. <year>1993</year>;<volume>31</volume>: <fpage>732</fpage>–<lpage>48</lpage>. Available: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/8336512">http://www.ncbi.nlm.nih.gov/pubmed/8336512</ext-link>
<?supplied-pmid 8336512?><pub-id pub-id-type="pmid">8336512</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0194415.ref025">
                <label>25</label>
                <mixed-citation publication-type="journal"><name><surname>Klabunde</surname><given-names>CN</given-names></name>, <name><surname>Potosky</surname><given-names>AL</given-names></name>, <name><surname>Legler</surname><given-names>JM</given-names></name>, <name><surname>Warren</surname><given-names>JL</given-names></name>. <article-title>Development of a comorbidity index using physician claims data</article-title>. <source>J Clin Epidemiol</source>. <year>2000</year>;<volume>53</volume>: <fpage>1258</fpage>–<lpage>67</lpage>. Available: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/11146273">http://www.ncbi.nlm.nih.gov/pubmed/11146273</ext-link>
<?supplied-pmid 11146273?><pub-id pub-id-type="pmid">11146273</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0194415.ref026">
                <label>26</label>
                <mixed-citation publication-type="other">US Census Bureau. 2011–2015 Puerto Rico Community Survey 5-Year Estimates. 2016.</mixed-citation>
              </ref>
              <ref id="pone.0194415.ref027">
                <label>27</label>
                <mixed-citation publication-type="journal"><name><surname>PORTELA</surname><given-names>M</given-names></name>, <name><surname>SOMMERS</surname><given-names>BD</given-names></name>. <article-title>On the Outskirts of National Health Reform: A Comparative Assessment of Health Insurance and Access to Care in Puerto Rico and the United States</article-title>. <source>Milbank Q</source>. <year>2015</year>;<volume>93</volume>: <fpage>584</fpage>–<lpage>608</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1111/1468-0009.12138">10.1111/1468-0009.12138</ext-link></comment>
<?supplied-pmid 26350931?><pub-id pub-id-type="pmid">26350931</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0194415.ref028">
                <label>28</label>
                <mixed-citation publication-type="journal"><name><surname>Sargent</surname><given-names>DJ</given-names></name>, <name><surname>Wieand</surname><given-names>HS</given-names></name>, <name><surname>Haller</surname><given-names>DG</given-names></name>, <name><surname>Gray</surname><given-names>R</given-names></name>, <name><surname>Benedetti</surname><given-names>JK</given-names></name>, <name><surname>Buyse</surname><given-names>M</given-names></name>, <etal>et al</etal><article-title>Disease-free survival versus overall survival as a primary end point for adjuvant colon cancer studies: individual patient data from 20,898 patients on 18 randomized trials</article-title>. <source>J Clin Oncol</source>. American Society of Clinical Oncology; <year>2005</year>;<volume>23</volume>: <fpage>8664</fpage>–<lpage>70</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1200/JCO.2005.01.6071">10.1200/JCO.2005.01.6071</ext-link></comment>
<?supplied-pmid 16260700?><pub-id pub-id-type="pmid">16260700</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0194415.ref029">
                <label>29</label>
                <mixed-citation publication-type="journal"><name><surname>Booth</surname><given-names>CM</given-names></name>, <name><surname>Nanji</surname><given-names>S</given-names></name>, <name><surname>Wei</surname><given-names>X</given-names></name>, <name><surname>Peng</surname><given-names>Y</given-names></name>, <name><surname>Biagi</surname><given-names>JJ</given-names></name>, <name><surname>Hanna</surname><given-names>TP</given-names></name>, <etal>et al</etal><article-title>Colon Cancer: A Population-Based Study</article-title>. <source>J Natl Compr Canc Netw</source>. Harborside Press, LLC; <year>2016</year>;<volume>14</volume>: <fpage>47</fpage>–<lpage>56</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.6004/JNCCN.2016.0006">10.6004/JNCCN.2016.0006</ext-link></comment>
<?supplied-pmid 26733554?><pub-id pub-id-type="pmid">26733554</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0194415.ref030">
                <label>30</label>
                <mixed-citation publication-type="journal"><name><surname>Boland</surname><given-names>GM</given-names></name>, <name><surname>Chang</surname><given-names>GJ</given-names></name>, <name><surname>Haynes</surname><given-names>AB</given-names></name>, <name><surname>Chiang</surname><given-names>Y-J</given-names></name>, <name><surname>Chagpar</surname><given-names>R</given-names></name>, <name><surname>Xing</surname><given-names>Y</given-names></name>, <etal>et al</etal><article-title>Association between adherence to National Comprehensive Cancer Network treatment guidelines and improved survival in patients with colon cancer</article-title>. <source>Cancer</source>. NIH Public Access; <year>2013</year>;<volume>119</volume>: <fpage>1593</fpage>–<lpage>601</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1002/cncr.27935">10.1002/cncr.27935</ext-link></comment>
<?supplied-pmid 23280510?><pub-id pub-id-type="pmid">23280510</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0194415.ref031">
                <label>31</label>
                <mixed-citation publication-type="journal"><name><surname>Upadhyay</surname><given-names>S</given-names></name>, <name><surname>Dahal</surname><given-names>S</given-names></name>, <name><surname>Bhatt</surname><given-names>VR</given-names></name>, <name><surname>Khanal</surname><given-names>N</given-names></name>, <name><surname>Silberstein</surname><given-names>PT</given-names></name>. <article-title>Chemotherapy use in stage III colon cancer: a National Cancer Database analysis</article-title>. <source>Ther Adv Med Oncol</source>. <year>2015</year>;<volume>7</volume>: <fpage>244</fpage>–<lpage>251</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1177/1758834015587867">10.1177/1758834015587867</ext-link></comment>
<?supplied-pmid 26327922?><pub-id pub-id-type="pmid">26327922</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0194415.ref032">
                <label>32</label>
                <mixed-citation publication-type="journal"><name><surname>McCleary</surname><given-names>NJ</given-names></name>, <name><surname>Meyerhardt</surname><given-names>JA</given-names></name>, <name><surname>Green</surname><given-names>E</given-names></name>, <name><surname>Yothers</surname><given-names>G</given-names></name>, <name><surname>de Gramont</surname><given-names>A</given-names></name>, <name><surname>Van Cutsem</surname><given-names>E</given-names></name>, <etal>et al</etal><article-title>Impact of Age on the Efficacy of Newer Adjuvant Therapies in Patients With Stage II/III Colon Cancer: Findings From the ACCENT Database</article-title>. <source>J Clin Oncol</source>. <year>2013</year>;<volume>31</volume>: <fpage>2600</fpage>–<lpage>2606</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1200/JCO.2013.49.6638">10.1200/JCO.2013.49.6638</ext-link></comment>
<?supplied-pmid 23733765?><pub-id pub-id-type="pmid">23733765</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0194415.ref033">
                <label>33</label>
                <mixed-citation publication-type="journal"><name><surname>Hanna</surname><given-names>NN</given-names></name>, <name><surname>Onukwugha</surname><given-names>E</given-names></name>, <name><surname>Choti</surname><given-names>MA</given-names></name>, <name><surname>Davidoff</surname><given-names>AJ</given-names></name>, <name><surname>Zuckerman</surname><given-names>IH</given-names></name>, <name><surname>Hsu</surname><given-names>VD</given-names></name>, <etal>et al</etal><article-title>Comparative analysis of various prognostic nodal factors, adjuvant chemotherapy and survival among stage III colon cancer patients over 65 years: an analysis using Surveillance, Epidemiology and End Results (SEER)-Medicare data</article-title>. <source>Color Dis</source>. <year>2012</year>;<volume>14</volume>: <fpage>48</fpage>–<lpage>55</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1111/j.1463-1318.2011.02545.x">10.1111/j.1463-1318.2011.02545.x</ext-link></comment>
<?supplied-pmid 21689262?><pub-id pub-id-type="pmid">21689262</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0194415.ref034">
                <label>34</label>
                <mixed-citation publication-type="journal"><name><surname>McGory</surname><given-names>ML</given-names></name>, <name><surname>Zingmond</surname><given-names>DS</given-names></name>, <name><surname>Sekeris</surname><given-names>E</given-names></name>, <name><surname>Bastani</surname><given-names>R</given-names></name>, <name><surname>Ko</surname><given-names>CY</given-names></name>. <article-title>A Patient’s Race/Ethnicity Does Not Explain the Underuse of Appropriate Adjuvant Therapy in Colorectal Cancer</article-title>. <source>Dis Colon Rectum</source>. <year>2006</year>;<volume>49</volume>: <fpage>319</fpage>–<lpage>329</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/s10350-005-0283-6">10.1007/s10350-005-0283-6</ext-link></comment>
<?supplied-pmid 16475031?><pub-id pub-id-type="pmid">16475031</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0194415.ref035">
                <label>35</label>
                <mixed-citation publication-type="journal"><name><surname>Ortiz-Ortiz</surname><given-names>KJ</given-names></name>, <name><surname>Ramírez-García</surname><given-names>R</given-names></name>, <name><surname>Cruz-Correa</surname><given-names>M</given-names></name>, <name><surname>Ríos-González</surname><given-names>MY</given-names></name>, <name><surname>Ortiz</surname><given-names>AP</given-names></name>. <article-title>Effects of type of health insurance coverage on colorectal cancer survival in Puerto Rico: a population-based study</article-title>. <name><surname>Goel</surname><given-names>A</given-names></name>, editor. <source>PLoS One</source>. Public Library of Science; <year>2014</year>;<volume>9</volume>: <fpage>e96746</fpage><comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1371/journal.pone.0096746">10.1371/journal.pone.0096746</ext-link></comment><?supplied-pmid 24796444?><pub-id pub-id-type="pmid">24796444</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0194415.ref036">
                <label>36</label>
                <mixed-citation publication-type="journal"><name><surname>Ortiz-Ortiz</surname><given-names>KJ</given-names></name>, <name><surname>Ortiz-Martínez de Andino</surname><given-names>JJ</given-names></name>, <name><surname>Torres-Cintrón</surname><given-names>CR</given-names></name>, <name><surname>Tirado-Gómez</surname><given-names>M</given-names></name>, <name><surname>González-Falero</surname><given-names>A</given-names></name>, <name><surname>Caballero-Varona</surname><given-names>D</given-names></name>, <etal>et al</etal><article-title>Effect of type of health insurance coverage on leukemia survival in adults in Puerto Rico</article-title>. <source>P R Health Sci J</source>. <year>2014</year>;<volume>33</volume>: <fpage>132</fpage>–<lpage>5</lpage>. Available: <ext-link ext-link-type="uri" xlink:href="http://www.ncbi.nlm.nih.gov/pubmed/25244883">http://www.ncbi.nlm.nih.gov/pubmed/25244883</ext-link>
<?supplied-pmid 25244883?><pub-id pub-id-type="pmid">25244883</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0194415.ref037">
                <label>37</label>
                <mixed-citation publication-type="journal"><name><surname>Santiago-Casas</surname><given-names>Y</given-names></name>, <name><surname>González-Rivera</surname><given-names>T</given-names></name>, <name><surname>Castro-Santana</surname><given-names>L</given-names></name>, <name><surname>Ríos</surname><given-names>G</given-names></name>, <name><surname>Martínez</surname><given-names>D</given-names></name>, <name><surname>Rodríguez</surname><given-names>V</given-names></name>, <etal>et al</etal><article-title>Impact of managed care health insurance system for indigent patients with rheumatoid arthritis in Puerto Rico</article-title>. <source>Clin Rheumatol</source>. NIH Public Access; <year>2013</year>;<volume>32</volume>: <fpage>763</fpage>–<lpage>9</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1007/s10067-013-2167-9">10.1007/s10067-013-2167-9</ext-link></comment>
<?supplied-pmid 23314687?><pub-id pub-id-type="pmid">23314687</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0194415.ref038">
                <label>38</label>
                <mixed-citation publication-type="journal"><name><surname>Rivera-Hernandez</surname><given-names>M</given-names></name>, <name><surname>Leyva</surname><given-names>B</given-names></name>, <name><surname>Keohane</surname><given-names>LM</given-names></name>, <name><surname>Trivedi</surname><given-names>AN</given-names></name>. <article-title>Quality of Care for White and Hispanic Medicare Advantage Enrollees in the United States and Puerto Rico</article-title>. <source>JAMA Intern Med</source>. NIH Public Access; <year>2016</year>;<volume>176</volume>: <fpage>787</fpage>–<lpage>94</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1001/jamainternmed.2016.0267">10.1001/jamainternmed.2016.0267</ext-link></comment>
<?supplied-pmid 27111865?><pub-id pub-id-type="pmid">27111865</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0194415.ref039">
                <label>39</label>
                <mixed-citation publication-type="journal"><name><surname>Abrams</surname><given-names>TA</given-names></name>, <name><surname>Brightly</surname><given-names>R</given-names></name>, <name><surname>Mao</surname><given-names>J</given-names></name>, <name><surname>Kirkner</surname><given-names>G</given-names></name>, <name><surname>Meyerhardt</surname><given-names>JA</given-names></name>, <name><surname>Schrag</surname><given-names>D</given-names></name>, <etal>et al</etal><article-title>Patterns of adjuvant chemotherapy use in a population-based cohort of patients with resected stage II or III colon cancer</article-title>. <source>J Clin Oncol. American Society of Clinical Oncology</source>; <year>2011</year>;<volume>29</volume>: <fpage>3255</fpage>–<lpage>62</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1200/JCO.2011.35.0058">10.1200/JCO.2011.35.0058</ext-link></comment>
<?supplied-pmid 21768462?><pub-id pub-id-type="pmid">21768462</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0194415.ref040">
                <label>40</label>
                <mixed-citation publication-type="journal"><name><surname>Aizer</surname><given-names>AA</given-names></name>, <name><surname>Chen</surname><given-names>M-H</given-names></name>, <name><surname>McCarthy</surname><given-names>EP</given-names></name>, <name><surname>Mendu</surname><given-names>ML</given-names></name>, <name><surname>Koo</surname><given-names>S</given-names></name>, <name><surname>Wilhite</surname><given-names>TJ</given-names></name>, <etal>et al</etal><article-title>Marital status and survival in patients with cancer</article-title>. <source>J Clin Oncol</source>. <year>2013</year>;<volume>31</volume>: <fpage>3869</fpage>–<lpage>76</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1200/JCO.2013.49.6489">10.1200/JCO.2013.49.6489</ext-link></comment>
<?supplied-pmid 24062405?><pub-id pub-id-type="pmid">24062405</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0194415.ref041">
                <label>41</label>
                <mixed-citation publication-type="journal"><name><surname>Zhang</surname><given-names>Q-W</given-names></name>, <name><surname>Lin</surname><given-names>X-L</given-names></name>, <name><surname>Zhang</surname><given-names>C-H</given-names></name>, <name><surname>Tang</surname><given-names>C-Y</given-names></name>, <name><surname>Zhang</surname><given-names>X-T</given-names></name>, <name><surname>Teng</surname><given-names>L-M</given-names></name>, <etal>et al</etal><article-title>The influence of marital status on the survival of patients with esophageal cancer: a population-based, propensity-matched study</article-title>. <source>Oncotarget</source>. <year>2017</year>; <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.18632/oncotarget.19446">10.18632/oncotarget.19446</ext-link></comment><?supplied-pmid 28977943?><pub-id pub-id-type="pmid">28977943</pub-id></mixed-citation>
              </ref>
              <ref id="pone.0194415.ref042">
                <label>42</label>
                <mixed-citation publication-type="journal"><name><surname>Inverso</surname><given-names>G</given-names></name>, <name><surname>Mahal</surname><given-names>BA</given-names></name>, <name><surname>Aizer</surname><given-names>AA</given-names></name>, <name><surname>Donoff</surname><given-names>RB</given-names></name>, <name><surname>Chau</surname><given-names>NG</given-names></name>, <name><surname>Haddad</surname><given-names>RI</given-names></name>. <article-title>Marital status and head and neck cancer outcomes</article-title>. <source>Cancer</source>. <year>2015</year>;<volume>121</volume>: <fpage>1273</fpage>–<lpage>1278</lpage>. <comment>doi: <ext-link ext-link-type="uri" xlink:href="https://doi.org/10.1002/cncr.29171">10.1002/cncr.29171</ext-link></comment>
<?supplied-pmid 25524565?><pub-id pub-id-type="pmid">25524565</pub-id></mixed-citation>
              </ref>
            </ref-list>
          </back>
        </article>
      </metadata>
    </record>
  </GetRecord>
</OAI-PMH>
